Council for Tobacco Research
Report of the Council for Tobacco Research-U.S.A., Inc. [St]
Abstract
MAR
Fields
- Depository Date
- 25 Sep 1995
- Master ID
- Ctrmn00000667-6967
Related Documents:- CTRMN000667-0808 Deposition of Robert F. Gertenbach [Deposition of Gertenbach in the Matter of Rogers]
- CTRMN000809-0827 Certificate of Incorporation of the Council for Tobacco Research - U.S.A., Inc. Under Section 402 of the Not-for-Profit Corporation Law [Details Definitions and Purposes for Forming A Not-for-Profit Corporation]
- CTRMN000828-0848 by-Laws of the Council for Tobacco Research - U.S.A., Inc. [Rules and Regulations for the Operation of the Council]
- CTRMN000849-0854 Application for Research Grant [A Blank Funding Request Form for Scientific Studies]
- CTRMN000855-0856 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Stipulations for Receiving A Funding Award]
- CTRMN000857-0859 [Suggestions and Guidelines for Submitting A Request for A Grant]
- CTRMN000860-0871 [Transmittal of Information for Securing A Research Grant]
- CTRMN000872-0882 [A Blank Funding Request Form for Scientific Studies]
- CTRMN000883-0892 Closing Dates for Application of Renewal Grants Requirements: (1) Progress Report and (2) Abstract of Progress Report [Procedural Information for Applying for Continued Funding for Scientific Project]
- CTRMN000893-1031 Published Reports on Research Supported in Whole or in Part by the Council for Tobacco Research - U.S.A. Formerly the Tobacco Industry Research Committee [List of Scientific Studies]
- CTRMN001032-1045 1956 Report of the Scientific Director [St]
- CTRMN001046-1094 1957 Report of the Scientific Director [St]
- CTRMN001095-1127 1958 Report of the Scientific Director [St]
- CTRMN001128-1163 1959 Report of the Scientific Director [St]
- CTRMN001164-1201 1960 Report of the Scientific Director [St]
- CTRMN001202-1239 1961 Report of the Scientific Director [St]
- CTRMN001240-1269 1962 Report of the Scientific Director [St]
- CTRMN001270-1306 Annual Report of the Scientific Director [St]
- CTRMN001307-1346 Report of the Scientific Director [St]
- CTRMN001347-1387 Report of the Scientific Director [St]
- CTRMN001388-1429 Report of the Scientific Director [St]
- CTRMN001430-1485 Annual Report of the Scientific Director [St]
- CTRMN001486-1529 Report of the Scientific Director [St]
- CTRMN001530-1578 Annual Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001579-1632 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001633-1681 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001728-1771 1975 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001772-1816 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001817-1860 1977 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001861-1913 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001914-1967 1979 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001968-2025 1980 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002026-2088 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002089-2148 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002149-2223 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002224-2942 Application for Research Grant An Investigation of the Spectral and Chromatographic Characteristics of Aromatic Hydrocarbons. [Study on High Temperature Gas-Liquid Partition Chromatography]
- CTRMN002943-3303 [Regarding Polio and Tuberculosis As Predisposing Factor in Lung Cancer]
- CTRMN003304-3322 Tobacco-Health Research Program [Display Case Showing Main Areas of Investigation]
- CTRMN003323-3326 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Rules for Approval of Grants Relating to Tobacco Use and Human Health]
- CTRMN003327-3337 A Brief Review of the Smoking-Lung Cancer Theory [Concerning Problems of Cigarette Lung Cancer Causation and Why They Have No Been Solved]
- CTRMN003338-3357 A Scientific Perspective on the Cigarette Controversy [Views of Cancer Experts on Causes of Lung Cancer]
- CTRMN003358-3365 Some Information About... The Council for Tobacco Research-U.S.A., Inc. ...and Its Research Program [Informs About the Purpose and Function of Organization's Research Program]
- CTRMN003366-3374 the Research Program of the Scientific Advisory Board to the Council for Tobacco Research - U.S.A. [Informs the Purposes, Policies, and the Research Program of the Board]
- CTRMN003375-3419 the Cancer-Smoking Controversy [Regards the Fallacious Conclusions of Cigarette Smoking Causing Lung Cancer From A Mathematical and Scientific Point of View]
- CTRMN003420-3425 Some Harvard Men & the Smoking Habit [Give Results of Questionnaire Relating to Biological Factors of Tobacco Smoking]
- CTRMN003426-3431 the Pathologic Anatomy of the Bronchial Tree and Lungs Reprinted From the Archives of Pathology Vol. 70 [St Finds of Equivocal Results with the Use of Tobacco]
- CTRMN003432-3437 Some Statistical Observations on A Co-Operative Study of Human Pulmonary Pathology Reprinted From the Proceedings of the National Academy of Sciences Vol. 43 No. 12 [St Examines Systematically the Conditions at Autopsy in the Bronchial Mucosae of Random Cases]
- CTRMN003438-3442 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology, II [Results Show Pathological Lungs in Different Cities Are Acutally Different]
- CTRMN003443-3447 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology. II [Study Comparing Pathological Conditions in 8 Different Cities Shows That Conditions Are All Different]
- CTRMN003448-3456 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology [Systematic Examinations of the Conditions at Autopsy in the Bronchial Mucosae of Run-of-the-Mill Cases]
- CTRMN003457-3464 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology III [When Probability Is Doubtful the Use of Variable Tables to Calculate Results Is the Best Way to Make A Precise and Accurate Answer for Sufficient Range of Pathological Conditions]
- CTRMN003465-3476 Differences Between Smokers and Nonsmokers [Differences Between Smokers and Nonsmokers Have to Do with Personality Traits and Physiologic Criteria]
- CTRMN003477-3485 the Psychology of Smoking [Smoking Is Determined by Certain Personality Variables and Personal Needs]
- CTRMN003486-3490 the Tobacco and Health Research Program of the Scientific Advisory Board [Regarding Information the Tobacco Industry Research Committee Do for the Research Program]
- CTRMN003491-3558 Tobacco Consumption in Various Countries [Results of Cigarette and Cigar Smokers From Different Countries]
- CTRMN003559-3560 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Guidelines for Which Grants Are Approved]
- CTRMN003561-3780 Tobacco Smoking in the United States in Relation to Income Marketing Research Report No. 189 [A Report Compiled by the Bureau of the Census for the United States Public Health Service on Smoking Characteristics in Relation to Income, Age, Region, Urban-Rural Residence and Occupation.]
- CTRMN003781-3781 Operating Results 1982 and Budget 1983 [Record of Expenditures]
- CTRMN003782-3782 Operating Results for Ten-Months Ended 10/31 Budget 11/1/83 Through 10/31/84 [Record of Expenditures]
- CTRMN003783-3783 Actual Operating Fiscal Year 1984 and Budget Fiscal Year 1985 [Record of Expenditures]
- CTRMN003784-3787 Confidential Report on Meeting January 18, 1954 Tobacco Industry Research Committee (TIRC) [St]
- CTRMN003788-3797 Confidential Report on Meeting March 15, 1954 Tobacco Industry Research Committee [St]
- CTRMN003798-3800 Tobacco Industry Research Committee Meeting [St]
- CTRMN003801-3815 Tobacco Industry Research Committee Meeting [St]
- CTRMN003816-3835 Tobacco Industry Research Committee Meeting [St]
- CTRMN003836-3852 Tobacco Industry Research Committee Meeting November 3, 1955 [St]
- CTRMN003853-3869 Tobacco Industry Research Committee Meeting February 14, 1956 [St]
- CTRMN003870-3895 Tobacco Industry Research Committee Meeting October 9, 1956 [St]
- CTRMN003896-3907 Tobacco Industry Research Committee Meeting May 9, 1957 [St]
- CTRMN003908-3923 Tobacco Industry Research Committee Meeting November 8, 1957 [St]
- CTRMN003924-3931 Tobacco Industry Research Committee Meeting May 8 1958 [St]
- CTRMN003932-3939 Tobacco Industry Research Committee Meeting November 6, 1958 [St]
- CTRMN003940-3945 Tobacco Industry Research Committee Meeting [St]
- CTRMN003946-3956 Tobacco Industry Research Committee Meeting December 10, 1959 [St]
- CTRMN003957-3969 Tobacco Industry Research Committee Meeting November 15, 1960 [St]
- CTRMN003970-3982 Tobacco Industry Research Committee Meeting October 18, 1961 [St]
- CTRMN003983-3991 Tobacco Industry Research Committee Meeting [St]
- CTRMN003992-4002 Tobacco Industry Research Committee Meeting November 15, 1962 [St]
- CTRMN004003-4006 the Council for Tobacco Research - U.S.A. March 5, 1964 [St]
- CTRMN004007-4014 the Council for Tobacco Research - U.S.A. June 8, 1965 [St]
- CTRMN004015-4020 the Council for Tobacco Research - U.S.A. January 27, 1967 [St]
- CTRMN004021-4026 the Council for Tobacco Research - U.S.A. January 24, 1968 [St]
- CTRMN004027-4034 the Council for Tobacco Research - U.S.A. January 31, 1969 [St]
- CTRMN004035-4041 Minutes of the First Meeting of the Board of Directors [St]
- CTRMN004042-4048 Minutes of the Second Meeting of the Board of Directors January 29, 1971 [St]
- CTRMN004049-4052 Minutes of the Meeting of the Executive Committee of the Board of Directors June 24, 1971 [St]
- CTRMN004053-4057 Minutes of of the Board of Directors January 28, 1972 [St]
- CTRMN004058-4061 Minutes of the Meeting of the Board of Directors November 10, 1972 [St]
- CTRMN004062-4066 Minutes of the Meeting of the Board of Directors January 26, 1973 [St]
- CTRMN004067-4070 Minutes of the Special Meeting of the Board of Directors July 26, 1973 [St]
- CTRMN004071-4076 Minutes of the Meeting of the Board of Directors February 1, 1974 [St]
- CTRMN004077-4081 Minutes of the Special Meeting of the Board of Directors June 13, 1974 [St]
- CTRMN004082-4086 Minutes of the Special Meeting of the Board of Directors December 5, 1974 [St]
- CTRMN004087-4091 Minutes of the Meeting of the Board of Directors January 31, 1975 [St]
- CTRMN004092-4095 Minutes of the Special Meeting of the Board of Directors July 24, 1975 [St]
- CTRMN004096-4141 Retirement Plan for Employees of the Council for Tobacco Research - U.S.A., Inc. Amended and Restated As of July 1, 1975 [St]
- CTRMN004142-4147 Minutes of the Special Meeting of the Board of Directors December 10, 1975 [St]
- CTRMN004148-4153 Minutes of the Meeting of the Board of Directors January 30, 1976 [St]
- CTRMN004154-4157 Minutes of the Special Meeting of the Board of Directors September 9, 1976 [St]
- CTRMN004158-4161 Minutes of the Meeting of the Board of Directors January 28 1977 [St]
- CTRMN004162-4166 Minutes of the Special Meeting of the Board of Directors April 21 1978 [St]
- CTRMN004167-4167 Minutes of the Special Meeting of the Executive Committee of the Board of Directors August 17, 1978 [St]
- CTRMN004168-4172 Minutes of the Meeting of the Board of Directors January 29, 1979 [St]
- CTRMN004173-4176 Minutes of the Meeting of the Board of Directors February 1, 1980 [St]
- CTRMN004177-4178 Minutes of the Board of Directors Executive Committee Meeting New York, New York [St]
- CTRMN004179-4184 Minutes of the Meeting of the Directors January 30, 1981 [St]
- CTRMN004185-4189 Minutes of the Special Meeting of the Board of Directors June 25, 1981 [St]
- CTRMN004190-4192 Minutes of A Meeting of Certain Members of the Board of Directors [St]
- CTRMN004193-4198 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004199-4205 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004206-4209 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004210-4213 Minutes of the Special Meeting of the Board of Directors [St]
- CTRMN004214-4217 Confidential Report of Scientific Advisory Board Meeting [St]
- CTRMN004218-4221 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004222-4226 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004227-4232 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004233-4236 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004237-4240 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004241-4246 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004247-4251 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004252-4256 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004257-4266 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004267-4283 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004284-4287 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004288-4292 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004293-4297 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004298-4303 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004304-4310 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004311-4316 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004317-4319 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004320-4323 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004324-4330 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004331-4335 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004336-4339 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004340-4344 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004345-4348 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004349-4353 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004354-4357 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004358-4366 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004367-4370 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004371-4376 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004377-4390 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004391-4395 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004396-4400 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004401-4404 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004405-4409 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004410-4413 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004414-4416 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004417-4420 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004421-4426 Confidential Report Scientific Board Meeting [St]
- CTRMN004427-4430 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004431-4433 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004434-4436 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004437-4439 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004440-4443 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004444-4446 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004447-4450 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004451-4454 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004455-4459 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004460-4463 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004464-4467 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004468-4472 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004473-4475 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004476-4480 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004481-4484 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004485-4492 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004493-4497 Confidential Report Scientific Advisory Board Meeting September 23-24, 1967 [St]
- CTRMN004498-4501 Confidential Report Scientific Advisory Board Meeting December 9-10, 1967 [St]
- CTRMN004502-4505 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004506-4510 Confidential Report Scientific Advisory Board Meeting La Jolla, California March 2-3-4, 1968 [St]
- CTRMN004511-4516 Confidential Report Scientific Advisory Board Meeting New York New York May 25-26, 1968 [St]
- CTRMN004517-4522 Confidential Report Scientific Advisory Board Meeting New York, New York September 14-15, 1968 [St]
- CTRMN004523-4526 Confidential Report Scientific Advisory Board Meeting New York, New York December 8-9, 1968 [St]
- CTRMN004527-4531 Confidential Report Scientific Advisory Board Meeting New York, New York March 22-23, 1969 [St]
- CTRMN004532-4538 Confidential Report Scientific Advisory Board Meeting New York, New York May 16-18, 1969 [St]
- CTRMN004539-4544 Confidential Report Scientific Advisory Board Meeting New York, New York September 12-14, 1969 [St]
- CTRMN004545-4549 Confidential Report Scientific Advisory Board Meeting New York, New York December 12-14, 1969 [St]
- CTRMN004550-4555 Confidential Report Scientific Advisory Board Meeting Colorado Springs, Colorado March 20-22, 1970 [St]
- CTRMN004556-4560 Confidential Report Scientific Advisory Board Meeting New York, New York [St]
- CTRMN004561-4569 Confidential Report Scientific Advisory Board Meeting New York, N.Y. September 18-19-20, 1970 [St]
- CTRMN004570-4578 Confidential Report Scientific Advisory Board Meeting Chicago, Illinois January 15,16, 1971 [St]
- CTRMN004579-4585 Confidential Report Scientific Advisory Board Meeting New York, N.Y. May 7-8-9, 1971 [St]
- CTRMN004586-4593 Confidential Report Scientific Advisory Board Meeting New York, N.Y. September 24-25-26, 1971 [St]
- CTRMN004594-4598 Confidential Report Scientific Advisory Board Meeting New York, N.Y. [St]
- CTRMN004599-4604 Confidential Report Scientific Advisory Board Meeting Palm Springs, California March 24-25-26, 1972 [St]
- CTRMN004605-4609 Confidential Report Scientific Advisory Board Meeting New York, New York June 9-11, 1972 [St]
- CTRMN004610-4614 Confidential Report Scientific Advisory Board Meeting New York, New York September 15-17, 1972 [St]
- CTRMN004615-4623 Confidential Report Scientific Advisory Board Meeting New York, New York March 14-15-16, 1973 [St]
- CTRMN004624-4626 Meeting Executive Committee of the Scientific Advisory Board June 13, 1973 New York, N.Y. [St]
- CTRMN004627-4634 Confidential Report Scientific Advisory Board Meeting New York, New York October 10-11-12, 1973 [St]
- CTRMN004635-4643 Meeting Executive Committee of the Scientific Advisory Board December 4, 1973 New York, N.Y. [St]
- CTRMN004644-4654 Confidential Report Scientific Advisory Board Meeting New York, New York October 30-31 November 1, 1974 [St]
- CTRMN004655-4656 Meeting Executive Committee of the Scientific Advisory Board December 13, 1974 New York, N.Y. [St]
- CTRMN004657-4664 Confidential Report Scientific Advisory Board Meeting Santa Barbara, California March 26-27-28, 1975 [St]
- CTRMN004665-4672 Confidential Report Scientific Advisory Board Meeting New York, New York September 10-11-12, 1975 [St]
- CTRMN004673-4675 Meeting Executive Committee of the Scientific Advisory Board New York, New York December 13, 1975 [St]
- CTRMN004676-4683 Confidential Report Scientific Advisory Board Meeting Santa Barbara, California March 17-18-19, 1976 [St]
- CTRMN004684-4686 Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 11, 1976 [St]
- CTRMN004687-4694 Confidential Report Scientific Advisory Board Meeting New York, New York September 28-29-30, 1976 October 1, 1976 [St]
- CTRMN004695-4697 Meeting of the Executive Committee of the Scientific Advisory Board Bethesda, Maryland December 1, 1976 [St]
- CTRMN004698-4706 Confidential Report Scientific Advisory Board Meeting Tuscon, Arizona March 23-25, 1977 [St]
- CTRMN004707-4708 Meeting of the Executive Committee of the Scientific Advisory Board Tuscon, Arizona March 25, 1977 [St]
- CTRMN004709-4710 Meeting of the Executive Committee of the Scientific Advisory Board New York, New York May 19, 1977 [St]
- CTRMN004711-4719 Confidential Report Scientific Advisory Board Meeting New York, New York October 26-28, 1977 [St]
- CTRMN004720-4723 Confidential Report Scientific Advisory Board Meeting Phoenix, Arizona January 16-17, 1978 [St]
- CTRMN004724-4724 Confidential Report Meeting of the Scientific Advisory Board Committee Phoenix, Arizona January 17, 1978 [St]
- CTRMN004725-4734 Confidential Report Scientific Advisory Board Meeting New York, New York April 26-27-28, 1978 [St]
- CTRMN004735-4735 Confidential Report Scientific Advisory Board Executive Committee New York, New York April 27, 1978 [St]
- CTRMN004736-4737 Confidential Report Meeting for the Scientific Advisory Board New York, New York July 27, 1978 [St]
- CTRMN004736A-4736A Confidential Report Meeting of the Scientific Advisory Board New York, New York July 27, 1978 [St]
- CTRMN004738-4747 Confidential Report Scientific Advisory Board Meeting New York, New York October 18-19-20, 1978 [St]
- CTRMN004748-4750 Confidential Report Meeting of the Scientific Advisory Board New York, New York December 20, 1978 [St]
- CTRMN004751-4759 Confidential Report Scientific Advisory Board Meeting New York, New York April 11-12-13, 1979 [St]
- CTRMN004760-4769 Confidential Report Scientific Advisory Board Meeting New York, New York October 17-18-19, 1979 [St]
- CTRMN004770-4770 Confidential Meeting of the Report Scientific Advisory Board New York, New York October 18, 1979 [St]
- CTRMN004771-4780 Confidential Report Scientific Advisory Meeting New York, New York Aprill 9-10-11, 1980 [St]
- CTRMN004781-4781 Confidential Report Executive Committee of the Scientific Advisory Board Meeting New York, New York June 20, 1980 [St]
- CTRMN004782-4783 Confidential Report Executive Committee of the Scientific Advisory Board Meeting New York, New York September 16, 1980 [St]
- CTRMN004784-4792 Confidential Report Scientific Advisory Board Meeting New York, New York October 8-9-10, 1980 [St]
- CTRMN004793-4794 Confidential Report Meeting of the Scientific Advisory Board New York, New York October 9, 1980 [St]
- CTRMN004795-4804 Confidential Report Scientific Advisory Board Meeting New York, New York April 8-9-10, 1981 [St]
- CTRMN004805-4805 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 8, 1981 [St]
- CTRMN004806-4806 Confidential Report Meeting of the Scientific Advisory Board New York, New York September 10, 1981 [St]
- CTRMN004807-4816 Confidential Report Scientific Advisory Board Meeting New York, New York October 14-15-16, 1981 [St]
- CTRMN004817-4818 Confidential Report Meeting of the Executive Committee Scientific Advisory Board New York, New York October 15, 1981 [St]
- CTRMN004819-4820 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York December 9, 1981 [St]
- CTRMN004821-4831 Confidential Report Scientific Advisory Board Meeting New York, New York April 21, 22, 23, 1982 [St]
- CTRMN004832-4833 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 21, 1982 [St]
- CTRMN004834-4843 Confidential Report Scientific Advisory Board Meeting New York, New York October 6,7,8, 1982 [St]
- CTRMN004844-4844 Confidential Report Meeting of the Executive Meeting of the Scientific Advisory Board New York, New York October 8, 1982 [St]
- CTRMN004845-4845 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board Scottsdale, Arizona February 24, 1983 [St]
- CTRMN004846-4857 Confidential Report Scientific Advisory Board Meeting New York, New York April 20, 21, 22, 1983 [St]
- CTRMN004858-4858 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 22, 1983 [St]
- CTRMN004859-4859 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 6, 1983 [St]
- CTRMN004860-4871 Confidential Report Scientific Advisory Board Meeting New York, New York October 12, 13, 14, 1983 [St]
- CTRMN004872-4882 Confidential Report Scientific Advisory Board Meeting New York, New York March 28, 29, 30, 1984 [St]
- CTRMN004883-4883 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York March 29, 1984 [St]
- CTRMN004884-4895 Confidential Report Scientific Advisory Board Meeting September 19, 20, 21, 1984 New York, New York [St]
- CTRMN004896-4896 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York September 20, 1984 [St]
- CTRMN004897-4897 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board Palm Beach, Florida February 25, 1985 [St]
- CTRMN004898-4898 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 16, 1985 [St]
- CTRMN004899-4910 Confidential Report Scientific Advisory Board Meeting April 15, 16, 17, 1985 New York, New York [St]
- CTRMN004911-4911 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 16, 1985 [St]
- CTRMN004912-4923 Confidential Report Scientific Advisory Board Meeting April 15, 16, 17, 1985 New York, New York [St]
- CTRMN004924-4927 for Release: A.M.'s Wednesday, April 14, 1954 ["Reaction to the Compendium "A Scientific Perspective on the Cigarette Controversy""]
- CTRMN004928-4929 for Release: A.M.'s Tuesday, April 27, 1954 [Scientific Advisory Board Organized Early to Begin Research Into All Phases of Tobacco Use and Health for the Year]
- CTRMN004930-4931 for Release in A.M.'s of Tuesday, May 18, 1954 [Proposals Submitted for Cancer Research Projects for Consideration by Scientific Advisory Board]
- CTRMN004932-4933 for Release After 10:30 A.M., June 15, 1954 [Appointment of Dr. Clarence Cook Little Announced by the Tobacco Research Industry Committee]
- CTRMN004934-4937 for Immediate Release [American Cancer Society Survey Conveys the Need to Further Research to Discover Cause of Cancer and Cardiovascular Disease]
- CTRMN004938-4939 for Release in Am's of Tuesday, July 20, 1954 [Edwin B. Wilson of Harvard University Became A Member of Scientific Advisory Board of the Tobacco Industry Research Committee]
- CTRMN004940-4942 for Release: A.M.'s of Wednesday, July 28, 1954 Little Announces Research Policy of Tobacco Industry Research Committee [Three Main Areas to Be Covered by Research Program Announced]
- CTRMN004943-4944 for Release in A.M.'s Thursday, August 19, 1954 [Dr. Julius H. Comroe of University of Pennsylvania, Accepted Membership on Scientific Advisory Board of the Tobacco Industry Research Committee]
- CTRMN004945-4945 for Immediate Release (Monday, October 11, 1954) Dr. Little Gives TIRC View [Little States That No Convincing Evidence Has Yet Been Found to Prove That Cigarette Smoking Causes Lung Cancer]
- CTRMN004946-4946 for Immediate Release (Tuesday, October 12, 1954) [Timothy V. Hartnet, Chairman of Board, Stated That Public Should Be Reminded That No Lung Cancer Causing Agent Has Yet Been Identified in Tobacco]
- CTRMN004947-4947 for Release: Wednesday, October 20, 1954 Hartnett Approves Care in Research [Committee to Be Sure That Reliable Evidence Is Available Before Announcing Important Conclusions to the Public About Smoking]
- CTRMN004948-4948 for Immediate Release (Thursday, October 21, 1954) Hartnett Comments on Cigarette Paper Burning [Timothy V. Hartnett Comments That A Cancer Causing Compound on Skin of Mice Has Been Produced by Burning Cigarette Paper Under Certain Lab Conditions]
- CTRMN004949-4952 for Release: A.M.'s, Monday, November 8, 1954 Tobacco Industry Research Committee Announces Initial Grants [Six Scientific Research Grants Totalling Over $82,000 Made Public]
- CTRMN004953-4954 for Release in A.M.'s, Monday, December 6, 1954 Scientific Associate Named by Tobacco Research Group [Robert C. Hockett Appointed As Scientific Director of TIRC to Help Develop Research Into Tobacco Use and Health]
- CTRMN004955-4956 for Immediate Release Cross-Country Lung Study Planned by Tobacco Group [Group of Pathologists Plan A Cooperative Study to Increase Knowledge of Lung Ailments]
- CTRMN004957-4959 for Release in Year-End Editions But Not Before December 27, 1954 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [TIRC Will Approve A Quarter of A Million Dollars for Research Into Public Health Problems by the End of 1954]
- CTRMN004960-4963 for Release: Monday A.M.'s, January 17, 1955 Tobacco Industry's New Research Grants Send Total to More Than $300,000 [New Research Grants Announced by TIRC to Relate to Both Human and Animal Scientific Studies]
- CTRMN004964-4966 for Release in A.M.'s of Friday, April 8, 1955 Tobacco Industry Group Votes Medical Research Fellowships [TIRC Announced Fellowship Program to Create Interest in Research Among Medical School Students]
- CTRMN004967-4969 Release Tuesday, May 17, 1955 and Thereafter Tobacco and Health Studies Cover Wide Range of Research [Although No Scientific Proof That Cigarettes or Air Pollution Cause Lung Cancer, Progress Is Being Made to Learn More About Tobacco Use and Health by the TIRC]
- CTRMN004970-4972 Tobacco Research Grants Increased to 490,000 Mark [Research Grants Are Created So Science Can Provide An Answer to Public Health Problems]
- CTRMN004973-4973 Hartnett Comments on Auerbach Paper [Many Studies on Human Lung Tissue, Not Enough Data Available to Draw A Conclusion Yet]
- CTRMN004974-4975 Anti-Smoking Theories Not Based on Complete Scientific Knowledge [Scientific Investigation Into What the Real Effects Are From Tobacco Use]
- CTRMN004976-4977 Hartnett Comments on Statistical Study [Research Intensified in Past Year, No Proof That Smoking Causes Cancer]
- CTRMN004978-4980 Doctor's Survey Termed 'biased, 'says Hartnett [Questionnaire Would Give No Concrete Conclusions About Tobacco Causing Cancer]
- CTRMN004981-4982 Hartnett Alerts Burley Men to Challenge Tobacco Attacks [Doctors Are Expressing Their Doubts About Statements Already Made; Tobacco Effects]
- CTRMN004983-4984 Bright Belt Warehouse Men Told Facts Challenge Critics [Still Looking for Proof That Tobacco Causes Cancer]
- CTRMN004985-4986 Tobacco Spokesman Says Facts and Position Are Unchanged [Various Experiments with Animals Showed That Cancer Was Not the Outcome From Tobacco Smoke]
- CTRMN004987-4987 Hartnett Comments on Statistical Study [Methods Used for Cancer Research Still Do Not Give Enough Information]
- CTRMN004988-4990 British Tobacco Experiments Unable to Induce Cancers [Still No Connection, Tests Will Continue]
- CTRMN004991-4993 Tobacco Research Grants Now Over 838,000 Mark [Tobacco Research Is Getting More Support From Doctors, Scientists, and Educators]
- CTRMN004994-4996 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Summary of the Past Years' Events in Tobacco Research]
- CTRMN004997-4999 Tobacco Research Fund Raised to 1,500,000 [Finding New Ways to Break Down Tobacco]
- CTRMN005000-5001 Tobacco Industry Group Renews Medical Research Fellowships [More Medical Students Are Receiving Fellowships Than Last Year]
- CTRMN005002-5003 Hartnett Statement on Cancer Meeting Reports [There Is Still Much Research to Be Done Before Tobacco Is Linked to Cancer]
- CTRMN005004-5005 [Pathologists From Around the Country Have Studied Human Lung Tissues Over the Past Year]
- CTRMN005006-5006 [Smoking Patterns Do Not Explain Differences in Lung Cancer]
- CTRMN005007-5008 Hartnett Cites British Tobacco Tests Failing to Produce Animal Cancer [the Search for Cancer Must Be Broadened and Intensified]
- CTRMN005009-5010 Hartnett Comments on Statistical Claims [Although Many Believe Smoking Causes Cancer, Scientists Still Have Not Found Any Prof]
- CTRMN005011-5011 [Present Knowledge Doesn't Hint A Relationship Between Smoking and Heart Problems]
- CTRMN005012-5016 Hartnett Comments on Cancer Society Booklet [Pamphlet Omits Some Important Research Results]
- CTRMN005017-5018 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Research Committee Needs More Scientific Investigation]
- CTRMN005019-5025 Tobacco Research Funds Reach 2.2 Million Mark [Over 60 Independent Scientists Throughout the Country Are Working in Institutions to Further the Research of Cancer and Tobacco Use, They Are Listed]
- CTRMN005026-5027 Hartnett Comments on French Report [French Are Reporting Rapid Cancer Formation in Mice, Hartnett Feels It Can't Be Judged on the Basis of New Reports Without Longer Consideration and Careful Analysis]
- CTRMN005028-5030 Harnett Cites Points for Clarification in Tobacco Health Study [Smoking Study Reached the Public's Attention Before It Was Reviewed and Before the Facts Were Made Crystal Clear]
- CTRMN005031-5032 Hartnett Comments on Wynder News Stories [News Story Claims That Assumptions Have Been Made About Mouse Skin Painting Experiments]
- CTRMN005033-5037 Statement on Smoking and Health Studies [Scientists Are Developing A Program for Different Phases of Tobacco Use and Health, Members Listed]
- CTRMN005038-5045 Hartnett Says Statistics Do Not Establish Causes [Studies Are Open to Assumptions and Certain Selection of Subjects]
- CTRMN005046-5048 Hartnett Cites Scientists Doubting Smoking-Cancer Theory [the Surgeon General Believes the Studies Are Missing Essential Facts That Should Be Acknowledged]
- CTRMN005049-5050 Scientist Comments on Benzpyrene Report [Benzpyrane in Tobacco Smoke, Under Investigation for Years Caused Cancer in Lab Animals But Not Humans]
- CTRMN005051-5055 "Cancer Researcher Challenges "Cause and Effect" Charges Against Smoking" [It's Difficult to Have A Cause and Effect Relationship When Dealing with Cancer and Tobacco Use]
- CTRMN005056-5056 [Atlantic Monthly Gives A Misleading Picture of Dr. Little and His Public Position]
- CTRMN005057-5058 Tobacco Committee Chairman Comments on Cancer Society Talk [Many Unresolved Questions About Tobacco Causing Cancer Don't Stop Researching]
- CTRMN005059-5061 Tobacco Research Scientist Discusses Smoking Question [Most Tend to Believe the Anti-Cigarette Theory But It Shouldn't Be Confused with the Facts There's Still Not Enough Facts to Prove That Smoking Causes Cancer]
- CTRMN005062-5062 Hartnett Says Leaflet Admits Differing Opinions on Smoking [Leaflet Tells How Scientists Disagree on Evidence]
- CTRMN005063-5066 Research Program Throws Doubts on Smoking Charges [Incorrect Claims and Harmful Effects From Tobacco]
- CTRMN005067-5069 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [More and More Scientists Had Doubts and Disbeliefs in the Charges Against Smoking As A Cause of Cancer]
- CTRMN005070-5071 Tobacco Research Scientist Discusses Smoking Question [Scientists Say Smoking Has Been Proved Guilty When Linked with Human Health Problems]
- CTRMN005072-5072 Pamphlet Merely Review, Dr. Little Says [Opinions Is All the Author Gives in His Pamphlet Scientists Are Still Disputing]
- CTRMN005073-5076 TIRC Fund for Research Boosted to $2,700,000 [Grants for Independent Scientists Interested in Studying Problems of Cancer and Heart Disease When Related to Smoking]
- CTRMN005077-5080 [New Knowledge on Smoking and Health Questions]
- CTRMN005081-5081 [Veterans Study of Smoking Habits]
- CTRMN005082-5082 [Report on How There Was Existing Research Evidence and How It Was Ignored]
- CTRMN005083-5085 [Regarding Anti-Tobacco Movement]
- CTRMN005086-5086 [Benzpyrene in Cigarette Smoke]
- CTRMN005087-5088 [Experimental Evidence Is Weak]
- CTRMN005089-5089 Hartnett Says Article on Arsenic Goes Beyond Facts [Farmers Use of Insecticides with Arsenicals on Growing Tobacco Has Steadily Been Declining]
- CTRMN005090-5091 [Scientists Who Produce Conflicting Results Are Being Ignored by the Health Department]
- CTRMN005092-5094 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Even More Grants Have Been Made Available More Factors Have Been Associated with Lung Cancer]
- CTRMN005095-5100 Tobacco Industry Group Announces Research Grants [Grant Increases to $3,200,000 List of Grants Announced]
- CTRMN005101-5103 Tobacco-Health Research Described in 1958 Report [the Report Talked About Experiments That Were Unable to Produce Cancer and the Cause and Effect Theory]
- CTRMN005104-5104 [Report Shows That Other Factors Besides Smoking Have Been Causing Lung Cancer, But Scientists Do Not Dismiss the Fact That Lung Cancer Is Possibility From Smoking]
- CTRMN005105-5105 [Anti-Smoking Campaign Is Thought to Be A One-Sided Propaganda Effort]
- CTRMN005106-5106 [Questions Arise From on-Sided Study]
- CTRMN005107-5111 Cancer Scientist's Comments on Smoking-Lung Cancer Review [Evidence on Smoking and Lung Cancer Is Accumulating, Among Other Contributing Factors]
- CTRMN005112-5117 [Comments Relating to Observation on Various Studies]
- CTRMN005118-5122 Research Grants Announced by Tobacco Industry Group [$500,000 Was Added to Research Funds, A List of Recipients with the New Grants Is Mentioned]
- CTRMN005123-5127 Research Supported by Tobacco Committee Discussed in Scientific Director's Report [It Seems That Finding An Answer to Lung Cancer and Cardiovascular Diseases Are Too Complicated]
- CTRMN005128-5128 [Attacks on Tobacco, the Lung Cancer Issue Is Still Not Settled]
- CTRMN005129-5129 Nta Stand on Smoking Repeats Opinions [Statement Gives No Evidence and Is Dealing Mainly with Opinions]
- CTRMN005130-5132 Tobacco Research Group Adds New Scientific Associate [New Scientific Director Was Added to the TIRC, Curriculum of J. Morrison Brady]
- CTRMN005133-5134 Tobacco Research Group Cites Questions Raised in Heart Statement [Lack of Evidence Proposes New Questions and Doubts About Cardiovascular Disease]
- CTRMN005135-5137 New Evidence Shows Complexities of Lung Cancer, Scientist Says [Hundreds of Studies Indicate Many Factors Contribute to the Complex Chain That May Result in Lung Cancer, No One Can Figure Out the Right Factor and Still the Reported Lung Cancer Cases Are Rising]
- CTRMN005138-5140 New Grants to Scientists Made by Tobacco Research Group [Research Grants Totalling $523,000 Made to 40 Scientists This Year]
- CTRMN005141-5144 Cancer Research Opens Up New Areas, Extra Funds Appropriated for Study [TIRC Stepping Up Financial Support of Independent Health Research]
- CTRMN005145-5147 Scientists in 11 States Get Research Grants for Tobacco-Health Studies [17 Research Grants Totaling Nearly $200,00 Awarded to Scientists in 11 States for Studies of Tobacco Use and Health]
- CTRMN005148-5151 New Direction for Tobacco-Health Research in '61, Says Chairman of Tobacco Industry Research Committee [Future Research to Concentrate on How Lung Cancer and Heart Disease Originate]
- CTRMN005152-5160 Research on Smoking and Health Discussed by Scientific Advisory Board to T.I.R.C. [Health Research Expansion Called for in 22 Specific Areas]
- CTRMN005161-5162 Scientist Reports on Research Progress As T.I.R.C. Boosts Funds to $4,650,000 [Dr. Clarence Cook Little Proposed Steps for Medical Research]
- CTRMN005163-5163 Nation's Medical Students Offered Research Fellowships by Tobacco Research Group [Program Designed to Encourage Research As A Career]
- CTRMN005164-5168 Scientists in 14 States Get Research Grants for Tobacco-Health Studies [Fifteen Grants for New Research Announced]
- CTRMN005169-5173 Tobacco Industry Research Committee Adds $800,000 for New Research [Emphasis Put on Viruses, Bioassay, Psychological and Physiological Research]
- CTRMN005174-5176 ""Significant Developments" in Cancer Research Reviewed in Annual Report by Dr. C.C. Little" [Scientific Findings of the Past Year Reviewed]
- CTRMN005177-5179 Tobacco Research Group Offers Fellowships to Medical Students to Spur Interest in Research Work [Program Designed to Encourage Career in Research]
- CTRMN005180-5180 Tobacco Research Committee Chairman Comments on Mouse Skin Painting [Harmless Everyday Substances Can Cause Cancer in Laboratory Animals]
- CTRMN005181-5182 Smoking-Health Situation Calls for Facts, Not Emotions, Says Hartnett [Repetition Does Not Add to Scientific Knowledge]
- CTRMN005183-5217 Smoking-Health Situation Calls for Facts, Not Emotions, Says Hartnett [Repetition Does Not Add to Scientific Knowledge]
- CTRMN005218-5224 52 Additional Research Grants Made by Tobacco Industry Group [Money for Studies Designed to Give New Leads to Lung Cancer and Other Health Problems]
- CTRMN005225-5225 Medical Student Fellowships Offered by Tobacco Research Group [Program to Encourage Research]
- CTRMN005226-5228 Gaps Still Exist in Knowledge of Lung Cancer and Heart Disease, Says Little [Multiple Factors and Influences That Contribute to Lung Cancer Unknown]
- CTRMN005229-5230 Scientific Director of Tobacco Industry Research Committee Comment on Resolution by American Heart Association [TIRC Welcomes Recognition of Need for Further Research to Determine Full Facts About Smoking]
- CTRMN005231-5234 Tobacco Committee Adds $1 Million for Continuing Research Studies [Scientific Advisory Board Assured TIRC Will Provide More Funds]
- CTRMN005235-5235 [Scientific Director of TIRC Sent Telegrams to the Surgeon General and the President of the Ama]
- CTRMN005236-5236 [Ama Supports Research on Tobacco and Health]
- CTRMN005237-5239 [TIRC Renamed and Reorganized]
- CTRMN005240-5241 Dr. Howard B. Andervont Named to the Scientific Advisory Board [Editor of the Journal of the National Cancer Institute Appointed]
- CTRMN005242-5277 Tobacco Industry Group Awards $817,165 for Health Research [37 Additional Research Grants Have Been Awarded by the Ctr]
- CTRMN005278-5282 Scientific Director C.C. Little Reports Decade of Tobacco-Health Research [Findings on What Diseases Smoking Can Cause]
- CTRMN005283-5286 Council Awards $500,000 for Tobacco and Health Research [Number of Grants Awarded for Tobacco Use and Health Research]
- CTRMN005287-5291 Summary of the Testimony of Clarence C. Little Before the Senate Commerce Committee [Discussion on Cancer and How It Affects Our Bodies]
- CTRMN005292-5319 Council Awards $514,767 for Tobacco and Health Research [Number of Grants Awarded to Scientist Over the Period of 10 Years]
- CTRMN005320-5348 Tobacco - Health Studies Reviewed in Annual Report [Discussion on Cigarette Smoking Being Helpful with Causing Diseases in Smokers]
- CTRMN005349-5367 Tobacco and Health Research Awards Pass $9 Million Total [Grants Given to Scientist Studying Matter Related to Tobacco Use and Health]
- CTRMN005368-5375 Tobacco-Health Research Grants Awarded New York Scientists [Scientists Approved to Continue Research on Lung Cancer and Other Diseases]
- CTRMN005376-5382 Tobacco - Health Studies Reviewed in Annual Report [Studies of the Respiratory System in Experimental Animals and Human Patients Especially on Causes of Pulmonary Cancers]
- CTRMN005383-5384 [Opinions of Scientists That There Is No Relationship Between Smoking and Disease]
- CTRMN005385-5387 New Tobacco-Health Research Grants Total $2 Million [Number of Approved Grants for Studies on Tobacco Use and Health]
- CTRMN005388-5388 Furst Becomes Consultant to Tobacco Research Council [Dr. Furst Advise to Council on Programs Sponsored by Them]
- CTRMN005389-5393 Studies Raise Questions About Smoking As Health Hazard [Numerous Studies Done to Show What Effect Smoking Had on Our Health]
- CTRMN005394-5400 Broad Review of Tobacco-Health Picture Covered in Dr. Little's Latest Report Lung Cancer, Heart Disease, Chronic Pulmonary Ailments Are Complex in Nature, Says Noted Researcher Genetic and Environmental Factors May Be Involved Reports Scientific Director of Council for Tobacco Research [Recent Research Finding on Lung Cancer, Heart Disease and Chronic Pulmonary Ailments]
- CTRMN005401-5404 Significant Smoking-Health Finding Covered in Report by Dr. C.C. Little [Findings From Independent Scientists on Smoking and Health]
- CTRMN005405-5408 New Tobacco-Health Grants Announced; One Helps Revive Framinghan Heart Study [Awards Granted to Independent Scientists Researching Tobacco and Health]
- CTRMN005409-5412 New Scientific Findings About Cancer, Heart Disease, the Lung, Other Areas, Reported by Council for Tobacco Research [New Findings From Independent Scientists Relating to Tobacco and Health Issue]
- CTRMN005413-5415 New Smoking-Health Studies Boost Total to $23-Million [Council Awards More Grants to the Study of Lung Cancer, Viruses and Cancer, Heart Disease, and Chronic Pulmonary Ailments]
- CTRMN005416-5418 Progress in Tobacco-Health Research Achieved: Machines That Simulate Human Smoking [Machines to Help Scientists Effectively Study Smoke and Health Issues]
- CTRMN005419-5421 Noted Cancer Scientist Named Scientific Director of the Council for Tobacco Research [Dr. Hockett Who Was Acting Scientific Director Got Promoted to Research Director]
- CTRMN005422-5425 Massive Cancer Study Using Made-to-Order Mice [Study Using Mice to See If Human Lung Cancer Can Be Induced Regularly]
- CTRMN005426-5427 Tobacco Research Group Announces New Studies [12 New Studies Have Been Funded to Study Generic Factors in Lung Cancer and Emphysema and the Possible Influence of Nicotine on Fetal Growth]
- CTRMN005428-5429 Studies of Twins Expanded by Tobacco Research Group [Human Twins Used for Study to Determine Effects of Environment Agents on Various Diseases]
- CTRMN005430-5432 News About Smoking and Health Study Interaction of Genetic and External Influences in Lung Cancer [Studies Show That Only Minority of Smokers Get Lung Cancer Therefore Lung Cancer May Be Caused by Genetic Characteristics or External Influences Which People Have Been Exposed]
- CTRMN005433-5434 New Smoking and Health Grants Made by Tobacco Research Council [New Studies Have Received Grants to Continue Researching on Smoking and Health]
- CTRMN005435-5435 Yeaman Assumes Leadership of Council for Tobacco Research [Addison Yeaman Succeeds H.H. Ramm for Chairman and President of the Council for Tobacco Research]
- CTRMN005436-5438 14 New Studies Funded by Tobacco Research Council [Grants Awarded to Studies for Inhibition of Cancer by Different Chemicals, the Influence of Nicotine on Pregnancy and the Effects of Cigarette Smoke on the Body's Disease Fighting System]
- CTRMN005439-5441 Progress Being Made in Research on Emphysema [Scientist Discover Ways to Help Defend Against Emphysema]
- CTRMN005442-5444 14 New Smoking-Health Projects Are Approved [Recent Research Studies Dealing with Smoking and Health Have Been Given Grants]
- CTRMN005445-5446 Grants Awarded for New Smiking-Health Studies [Scientists Were Approved for Studying of Certain Enzymes in Human Lung Cancer and Emphysema]
- CTRMN005447-5448 Tobacco Research Report Discusses Heart Disease [Studies Have Found Progressive Atherosclerosis Rank First As Number One As Causes of Death From Cardiovascular Disease]
- CTRMN005449-5451 Grants Awarded for New Smoking-Health Research [New Studies Have Been Approved for Marker Substance That May Indicate Presence of Lung Cancer and on Smoking and Pregnancy]
- CTRMN005452-5453 Tobacco Research Group Funds New Smoking-Health Projects [A New Study for Relationship of Childhood Respiratory Disease to the Development of Adult Chronic Lung Disease]
- CTRMN005454-5455 Tobacco Research Group Reports... Funds for Smoking-Health Studies Pass $46,000,000 [Amount Council Has Given to Scientist for Research]
- CTRMN005456-5458 $5.9 Millions Given for Smoking-Healths Studies [Council Has Given Millions Over the Years to Researchers]
- CTRMN005459-5460 Tobacco Research Group Says... Continued Research Needed to Find Causes of Cancer and Other Major Diseases [Council Pledges to Continue to Give Financial Support to Scientists Studying Smoke-Health Issues]
- CTRMN005461-5462 $6 Million Granted for Smoking-Health Studies [Millions Given to Scientist for Further Study]
- CTRMN005463-5465 Tobacco Research Group Continues Funding for Independent Scientists [Council Has Provided Millions Over the Years to Researchers and Will Continue to Do So]
- CTRMN005466-5467 $5.5 Million Given for Smokin-Health Studies [Council Has Given Millions to New and on Going Studies Over the Years]
- CTRMN005468-5469 Annual Report Issued by Tobacco Research Group [Over 1.5882 Reports From Scientists Acknowledging Support From the Council Have Been Published]
- CTRMN005470-5473 $6 Million Awarded for 34 New Smoking-Health Studies [Millions Were Given to Scientists with New Studies and Continuing Ones From the Council]
- CTRMN005474-5474 Ctr's Latest Report Sets Abstract Record [More Reports Were Published From Scientists Acknowledgingg Support From Council for Tobacco Research Than Any Other Report Published in the Past]
- CTRMN005475-5475 Scientists Show... Growing Interest in Doing Smoking and Health Studies [Growing Number of Application Have Gone to the Council of Tobacco Research for Funding on Smoke Related Diseases]
- CTRMN005476-5479 $7 and A Half -Million Awarded for Smoking-Health Research [Millions Given to Scientists for Studying Lung Disease]
- CTRMN005480-5481 Council for Tobacco Research Announces... Hoyt and Hockett Retire After 30 Years: Gertenbach Is Named New President [Introduction to President of the Council for Tobacco Research]
- CTRMN005482-5482 Ctr's Annual Report Sets Abstract Record [the Number of Reports Acknowledging Support by the Council of Tobacco Research Is More Today Than It Was Years Ago]
- CTRMN005483-5485 Findings Published on Cigarette Smoke Inhalation Study with Mice [Results From Study Show That Smoke Did Not Produce Any Squamous Cell Lung Cancer]
- CTRMN005486-5525 Statement of Dr. Clarence Cook Little, Scientific Director, Tobacco Industry Research Committee, at Press Conference, University Club, New York City, June 15, 1954 [Regarding Relationship Between Lung Cancer and Tobacco]
- CTRMN005526-5533 "Transcript of Edward R. Murrow's First Tv Show on "Cigarettes and Lung Cancer"" [Regarding Experiments That Show That Cigarette Smoking Increases Chances for Lung Cancer]
- CTRMN005534-5541 "Transcript of Edward R. Murrow's Second Tv Show on "Cigarettes and Lung Cancer"" [Regarding Issue That Cigarette Smoke Does Not Cause Lung Cancer]
- CTRMN005542-5562 the Lung Cancer Problem and the Research Program of the Tobacco Industry Research Committee [Regarding Continuation of Study Dealing with Tobacco and Health]
- CTRMN005563-5573 A Report of Progress [Results From the Study of Smoking and Health Issue Will Greatly Depend on Well Planned and Well-Executed Scientific Research]
- CTRMN005574-5585 Tobacco and the Cardiovascular System the Program of the Tobacco Industry Research Committee [Program Strives to Discover Facts and Relationships Described with Objectivity]
- CTRMN005586-5597 A Search for Facts [Regarding Information Needed to Be Gathered on Smoking and Health Problems to Defend Industry]
- CTRMN005598-5605 the Lung Cancer Problem and the Research Program of the Tobacco Industry Research Committee [Discussion on Different Studies Will Continue to Be Made Until A Answer Is Found]
- CTRMN005606-5607 Cancer Research Guest Editorial Smoking and Lung Cancer Volume 16 [St Regarding Support Given to Scientist for Research]
- CTRMN005608A-5609 "Correspondence Regarding "Smoking and Health"" [Discussion on Researching on Tobacco and Health with Objectivity and Not Be Judgmental]
- CTRMN005608B-5609 Hypfibrinogenemia [Regarding Transfusions and Clotting Mechanism in A Case of Extraordinarily Delayed Post-Partum Hemorrhage]
- CTRMN005608C-5609 Diabetic Children [Admitting Omission of Different Data From Other Sources]
- CTRMN005608D-5609 Revocation of Licenses [Revoking of Registration From Dr. Louis A. Scinta]
- CTRMN005610A-5613 Mayo Clinic Head Believes Smoking Not Cancer Cause Tobacco and Health Volume 1 Number 1 [Smoking Not Believed to Be Cause of Lung Cancer, According to Some Noted Physicians]
- CTRMN005610B-5613 Six Experts State Doubts on Smoking-Cancer Theory Tell Congressmen Reasons for Position Tobacco and Health Volume 1 Number 1 [Reasons for Not Accepting Theory That Smoking Causes Lung Cancer]
- CTRMN005610C-5613 New Book Says Tobacco 'scare' Not Justified Tobacco and Health Volume 1 Number 1 [""Science Looks at Smoking"]
- CTRMN005610D-5613 Editors View Smoking-Cancer Tie As Unproved, Open Question Excerpts From Editorials Tobacco and Health Volume 1 Number 1 [Excessive Smoking Probably the Main Cause of Lung Cancer, While Moderate Smoking As Causation of Lung Cancer Has No Scientific Support]
- CTRMN005610E-5613 British Scientist Opposes Campaign Against Smoking Tobacco and Health Volume 1 Number 1 [Sir Ronald Fisher, British Statistician, Refuses to Produce Anti-Smoking Writing, States It As A Cause for Anxiety]
- CTRMN005610F-5613 'pick Your Expert, Take Your Choice' Tobacco and Health Volume 1 Number 1 [Witnesses Linking Cigarettes to Lung Cancer Testify Before House Operations Sub-Committee]
- CTRMN005610G-5613 'still Open Question' Tobacco and Health Volume 1 Number 1 [Authorities on Cancer State That Smoking Is Not Proven to Cause Lung Cancer]
- CTRMN005610H-5613 Smoking and Death Rates Tobacco and Health Volume 1 Number 1 [If Everyone Stopped Smoking There Would Be No Significant Change in Death Rate]
- CTRMN005614-5616 Summary of Comments for Delivery Before: Central Subsection, North Jersey Section, American Chemical Society, Elizabeth, New Jersey [Review of the Chemical Analysis of Cigarette Smoke and Investigations of Smoking and Lung Cancer]
- CTRMN005617-5620 the Public and Smoking Fear or Calm Deliberation? [How Doubt, Suspicion and Fear May Affect the Deliberation of Whether Cigarette Smoking Causes Lung Cancer or Other Ailments]
- CTRMN005621A-5624 TIRC Reports Progress in Smoking-Health Research Tobacco and Health Volume 1 Number 2 [Too Many Unknowns Exist Concerning Lung Cancer to Warrant Conclusions Citing Smoking As Causation of Lung Cancer]
- CTRMN005621B-5624 'tar' Misnomer for Condensed Smoke Tobacco and Health Volume 1 Number 2 [Difficulties in Analyzing Tobacco Smoke Make Tobacco Tar A Misnomer]
- CTRMN005621C-5624 New Statistics Contradict Anticigarette Theory Tobacco and Health Volume 1 Number 2 [Cigarette Smoking May Be Compatible with Normal Health Report on Done Smokers Who Have Longer That Average Life Span]
- CTRMN005621D-5624 TIRC Funds for Smoking Research Now Over $2,000,000 Tobacco and Health Volume 1 Number 2 [Scientific Advisory Board Approves 52 Grants and Renewals in 1957 Totalling $550,000]
- CTRMN005621E-5624 Press Questions Anti-Smoking Plan Tobacco and Health Volume 1 Number 2 [State-Supported Campaign Against Cigarettes Warranted in New York]
- CTRMN005621F-5624 Study Suggests Bronchitis May Be Prime Factor in Lung Cancer Tobacco and Health Volume 1 Number 2 [Preliminary Study at Beatty Institute Favors Bronchitis As A Factor of Lung Cancer]
- CTRMN005621G-5624 Doctors' Comments on Smoking-Health Tobacco and Health Volume 1 Number 2 [Increasing Number of New Chemicals in the Atmosphere at Fault for Rise in Cancer]
- CTRMN005621H-5624 Nation-Wide Lung Tissue Study Now Being Evaluated Tobacco and Health Volume 1 Number 2 [TIRC Studying Lung Tissues From 1,600 Persons]
- CTRMN005625-5648 Biological Aspects of Cancer Research Journal of the National Cancer Institute Vol. 30, No. 3 [St Background Research and New Information on Cancer Studies]
- CTRMN005649-5654 Interview the Cigaret Smoker and Lung Cancer Reprinted From Modern Medicine, Vol 26 [St Advises on Smoking and Its Relation to Health]
- CTRMN005655-5660 Comments on the Mortality of Smokers and Non-Smokers. A Paper by Harold W. Dorn Before the American Statistical Association Dec. 27, 1958 [Reflections on Figures Presented in Dorn's Paper]
- CTRMN005661-5671 An Experimentalist Looks at Statistics on Smoking [Reflections on the Figures in Dorn's Paper]
- CTRMN005672-5672 Letters to the Times Findings on Smoking [Statistical Proof of Link Between Smoking and Cancer Denied]
- CTRMN005673-5683 A Brief Review of the Smoking-Lung Cancer Theory [Review of Data Known on the Relation Between Cigarette Smoking and Lung Cancer]
- CTRMN005684-5686 Cancer-the Research Approach [Discussion on Cancer and A Category of Factors Which May Play Roles in Cause and Development of Cancer]
- CTRMN005687-5692 [Address Before the Burley and Dark Leaf Tobacco Export Association, Inc. Information About the Research Program Supported by the TIRC]
- CTRMN005693-5697 Some Phases of the Problem of Smoking and Lung Cancer the New England Journal of Medicine Vol. 264 No. 24 [St Disputes Findings That Smoking Causes Lung Cancer]
- CTRMN005698-5704 Some Aspects of the Lung Cancer Problem Reprinted From Punjab Medical Journal Vol. Xi No. 7 [St Discussion of Relationship of Cigarette Smoking to Lung Cancer]
- CTRMN005705-5735 Current Knowledge of Tobacco and Health [Discussion of Experimental Attack on Lung Cancer and Tobacco Use]
- CTRMN005736-5739 Cigarettes-Why More Research? Reprinted From the Yale Scientific Magazine [St Comments on the Uncertainties of the Correlations Between Cigarette Smoking and Lung Cancer]
- CTRMN005740-5740 Why Do People Think That Quitting Smoking Affects Their Appetite or Their Weight? the Apothecary [St Comments on the Scientific Basis of How Smoking Affects Hunger]
- CTRMN005741-5754 Address to Be Delivered by Dr. Clarence Cook Little, Scientific Director, the Council for Tobacco Research - U.S.A. At A Dinner Honoring the Centennial of the University of Kentucky and the Burley Tobacco Industry Lexington, Kentucky January 12, 1965 [Talk Addressing Research Programs of the University of Kentucky]
- CTRMN005755-5772 Communications and the Biological Sciences [Brief Discussion of Principles That Should Inspire and Guide Communications in the Biological Sciences]
- CTRMN005773-5785 Perspectives in the Experimental Approach to the Human Lung Cancer Problem [Experimental Research on Lung Tumors in Animals May Lead to Insights on Human Lung Cancer]
- CTRMN005786-5798 Tobacco and Health Research [Elaboration on the Purpose, Research Practices and Studies of the TIRC]
- CTRMN005799-5805 Tobacco and Health Research [Discussion of Experimental Studies by the TIRC Concerning Smoking and Health]
- CTRMN005806-5813 the Research Perspective on Smoking and Health [Discussion on the Search for Causes of Diseases with Which Smoking Has Been Associated]
- CTRMN005814-5820 Tobacco and Health Research [Discussion of Studies on Cigarettes and the Diseases Statistically Associated with Smoking]
- CTRMN005821-5834 Tobacco and Health Research - Where Shall We Go From Here? [Suggestions for Continuing Studies and Research on Cigarette Smoking and Health]
- CTRMN005835-5852 A Look Ahead Smoking and Health - Where Do We Stand? [Talk on Chronic Diseases and Factors of Their Causation and Development in Relation to Cigarette Smoking]
- CTRMN005853-5854 Smoking-Disease Links Continue to Lack Scientific Proof [Discusses the Role of the Council for Tobacco Research]
- CTRMN005854-5854 Lawrence Promoted to Vp Post at Mmi [Jack Riddle Announces the New Vp of Micro-Magnetic Industries]
- CTRMN005854A-5854 Philip Morris Expands Promotional Allowances [Discusses Special Offers Made to Philip Morris Vendors]
- CTRMN005855-5882 Chapter 3 the Tobacco Health Issue: An Overview of Medical Research [St Questions Methodology of Experiments Where the Sole Objective Was the Attempt to Induce Tumors]
- CTRMN005883-5900 the Research Program (Cancer Segment) of the Council for Tobacco Research - U.S.A., Inc. Presentation Before the Tobacco Working Group [Describes the Concept, Plan, and Purpose of the Council for Tobacco Research]
- CTRMN005901-5902 Smoking Prevention Education Act Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Eighth Congress First Session on H.R. 1824 [Statement of Sheldon C. Sommers]
- CTRMN005903-5919 [Regarding Anti-Smoking Bill]
- CTRMN005920-5931 Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Eighth Congress First Session on H.R. 1824 March 9 and 17, 1983 Serial No. 98-8 Statement of Robert Casad Hockett Regarding H.R. 1824 [Disputes Findings Set Forth in H.R. 1824 Regarding Cancer, Cardiovascular Disease, Atherosclerosis and Emphysema]
- CTRMN005932-5932 Hearings Before the Committee on Labor and Human Resources United States Senate Ninety-Eighth Congress First Session on S. 772 May 5 and 12, 1983 [Concerning Smoking Prevention Health and Education Act of 1983]
- CTRMN005933-5940 Statement of Sheldon C. Sommers, M.D., Consultant in Pathology, Lenox Hill Hospital, New York, N.Y. [Comments on Smoking Prevention Health and Education Act]
- CTRMN005941-5963 Hearings Before the Committee on Labor and Human Resources United States Senate Ninety-Eighth Congress First Session on S. 772 to Promote Public Health by Improving Public Awareness of the Health Consequences of Smoking and to Increase the Effectiveness of Federal Health Officials in Investigating and Communicating to the Public Necessary Health Information, and for Other Purposes Statement of Robert Casad Hockett Regarding S. 772 [Disputes Methodology of Experiments Which Expose Animals to Smoke]
- CTRMN005964-6009 Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Seventh Congress Second Session on H.R. 5653 and H.R. 4957 March 5, 11, and 12, 1982 Serial No. 97-106 [Disputes Methodology of Experiments to Demonstrate That Cigarette Smoking Can Cause Lung Cancer in Animals]
- CTRMN006010-6012 Testimony of Dr. Robert C. Hockett During Hearing on Cigarette Smoking and Health Before the Subcommittee on Oversight and Investigations of the House Committee on Interstate and Foreign Commerce, October 5, 1978 [Responds to Question Regarding Research on Health and Smoking]
- CTRMN006013-6023 Statement of Robert C. Hockett, Ph.D. Before the Subcommittee on Oversight and Investigation of the Committee on Interstate and Foreign Commerce in Response to the Letter Dated September 27, 1978 From the Chairman of the Subcommittee to William U. Gardner, Ph.D., Scientific Director, the Council for Tobacco Research - U.S.A., Inc [Discusses the Purpose of the Council for Tobacco Research]
- CTRMN006024-6069 Hearings Before the Subcommittee on Health of the Committee on Labor and Public Welfare United States Senate Ninety-Fourth Congress Second Session on S. 2902 February 19, March 24, and May 27, 1976 [Disputes Scientific Basis of S. 2902]
- CTRMN006070-6125 Hearings Before the Consumer Subcommittee of the Committee on Commerce United State Senate Ninety-Second Congress Second Session on S. 1454 Serial No. 92-82 [Discussion of Cigarette-Smoking and Peptic Ulcers]
- CTRMN006126-6135 Report of the Scientific Director [St]
- CTRMN006136-6189 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 February 1, 5, and 10, 1972 [Discusses Edimeological Comparisons Between Smokers and Non-Smokers]
- CTRMN006190-6200 [Bibliography Listing Over 1,275 Articles and Books About Tobacco and Disease]
- CTRMN006201-6311 [Articles About Tobacco and Disease]
- CTRMN006312-6321 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statement of Dr. Sheldon C. Sommers]
- CTRMN006322-6348 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statement of Dr. Robert Casad Hockett]
- CTRMN006349-6359 Hearings Before the Consumer Committee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statements of Dr. Sheldon C. Sommers and Dr. Robert C. Hockett]
- CTRMN006360-6370 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [References Reporting on Tobacco and Nicotine]
- CTRMN006371-6412 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Ninety-First Congress First Session on H.R. 643 A Bill to Amend the Federal Cigarette Labeling and Advertising Act with Respect to the Labeling of Packages of Cigarettes and for Other Purposes (and Similar Bills) [Statement of Dr. Sheldon C. Sommers]
- CTRMN006413-6492 Hearings Before the Committee on Commerce United States Senate Eighty-Ninth Congress First Session on S. 559 and S. 547 Bills to Regulate Labeling of Cigarettes and for Other Purposes [Statement of Dr. Clarence C. Little]
- CTRMN006493-6533 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug, and Cosmetic Act So to Make That Act Applicable to Smoking Products [Statement of the Council for Tobacco Research U.S.A. History and Organization]
- CTRMN006534-6540 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug and Cosmetic Act So As to Make That Act Applicable to Smoking Products [Statement of Clarence Cook Little, SC.D.]
- CTRMN006541-6548 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug, and Cosmetic Act So As to Make That Act Applicable to Smoking Products [Statement of Robert Casad Hockett, Ph.D.]
- CTRMN006549-6577 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Statement of Dr. Clarence Cook Little]
- CTRMN006578-6611 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Statement Concerning the Origin and Purpose of the Tobacco Industry Research Committee and Its Proposed Functions]
- CTRMN006612-6614 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Hartnett Cites Scientists Doubting Smoking-Cancer Theory]
- CTRMN006615-6618 Research Into Smoking and Health [Arguments Against Tobacco Cancer Link]
- CTRMN006619-6623 [Study to Examine Reported Causes of Death in Each of 17 Regions in Houston Specifically the Five Major Respiratory Diseases]
- CTRMN006624-6624 A Frank Statement to Cigarette Smokers [Industry Promotes Research Into Tobacco Disease Link]
- CTRMN006625-6625 the Council for Tobacco Research - U.S.A., Inc. Board of Directors [Members of the Board]
- CTRMN006626-6627 the Council for Tobacco Research - U.S.A., Inc. Scientific Advisory Board [Members of the Board]
- CTRMN006628-6634 No. E-121,486 I. D. Rogers, Individually and As Independent Executor of the Estate of Marjorie Helen Rogers, Deceased; Et Al Vs. R. J. Reynolds Tobacco Company, Et Al in the District Court of Jefferson County, Texas 172nd Judicial District Third Amended Notice of Intention to Take Oral Deposition [Matters on Which Ctr Witnesses Must Be Knowledgeable]
- CTRMN006635-6967 Deposition of Dr. James Glenn [Deposition of Glenn in the Matter of Broin]
- Author
- Ramm, H.H., Ctr
- Request
- 118
- Type
- ANNUAL REPORT
- Box
- 002
- UCSF Legacy ID
- gnq30a00
Document Images
Of
THE COUNCIL FOR
TOBACCO RESEARCI I -U.S.A., Inc.
1974 '.
: 4t.. iI

m
I'l 7 1 li 1: 1' U!t 1' ct:
F_
U
o/
rllE caluNc:ll. FOR TOlt.lc:tY)
rlls: COUNrls. VOIC 1l,4.
1 10 li:A.l 1lrrol, Nvu 1'ur{., n.Y. 111/Y_°

SC1EtiTIFIC ADViSORY BOARD
to The Council for Tobacco Rcscarch-U.S.A., Inc.
as of Deecmbcr 31, 1974
SHELDON C. SOMMERS, M.D., Chairman
Directorof Laboratories, Lenox Hill Hospital
Clinical Pro/cssur of l'athology
Collcgc of Physicians & Surgeons of Columbia llnivcrsity
Ncw Yurk, Ncw York
RICHARD M. BING, M.D.
Director of Cardiology and Intramural Medicine
Huntington Mcmorial Hospital, Pasadena, Cali(urnia
PruJessor of Medicine
University of Southern California School of Mcc7icinc
Los Angclcs, California
JOSEPH D. FELDMAN, M.D.
Nead, Department of Immunopathology
Scripps Clinic and Rcsearch Foundation
La Jolla, California
WlLLIAM U. GARDNER, PH.D.
ScicntiJic Director, The Council for Tobacco Rcscarch-U.S.A., I nc.
E. K. Nunt Professor of Anatomy (enuritus)
Yale University School of Medicine
New Havcn, Connccticut
ROBERT J. HUEBNER, M.D.
Chief, Viral Carcinogenesis Program
National Cancer Institute
Bethesda, Maryland
LEON O. JACOBSON. M.D.
Dean of rhe Division of Biological Sciences
Regenstein Professor of Biological Sciences
University of Chicago
Chicago, Illinois
AVERILL A. LIEBOW, M.D.
Professor and Chairman. Department of Pathology
University of California School of Medicine
San Dicgo, California
HENRY T. LYNCH. M.D.
ProJessar and Chairman
Department of Preventive Medicine and Public Iicalth
Creighton University School of Mcdicinc
Omaha, Nebraska
i
HANS M~II:R. D.V.M., Dr. Mcd. Vet.. M.R.S.I1.
.Senmr .Sta/J .Scien ti.u
Thc Jack.on Latxiratory
Rar Harbor, Maine
JOHN P. WYA'iT, M.D.
I)irector
Tubaccn and I Icaith Rcscarch Institutc
University of Kcntucky
Lcxinl;tun, Kcntucky
Scientific St.ff of The Council
WILLIAM U. GARDNER, Pri.D.
Scientific Director
ROBERT C. HOCKETT, Ptt.D.
Research Director
JOfIN !f. KREaS1iER, Ptt.D. FREDERIC W. NORDSIEK, PH.D.
AsslKYare Research I)Irector
DA V I D STON E, Ptt. D.
Associare Rrsearch Director
Associate Research Director
VINCENT F. LISANTI. D.M.D.
Research Associate

Introduction
CONTENTS
Introduction . . ' ' 5
Canccr-Rclatcd Studics . . . . ' ' 7
Abstracts of Reports . . . . ' 13
Canccr-Rclated Studics . . . . 13
Thc Rcspiratory System . . . . 20
Hcart and Circulation . . . . . . . . . . . . 33
Ncuropharmacology and Psychophysiology . . . . . . 43
Pharmacology . . . . . . . . . . . . . 47
Immunology and Adaptive Mechanisms . . . 52
Epidemiology . . . . . . . . . . . . . . . . 58
Misccllarxous . . . . . . . . . 69
Active Projects . . . . . . . . . . . 72
Completed Projects . . . . 79
Index of Senior Authors . . . . . . . . . . 88
Indu of Principal Authors . . . . 89
The invcstigations supportcd by The Council for Tobacco Research -
U.S.A.. Inc. that were published during 1974 arc summarized in this Annual
Report under their specific titlcs. These investigations relate largcly to studies
of cigarctte smoking and smoke derivatives and problems of health. They have ~
bccn grouped into categories that are oricnted toward either specific diseases or
organs, or that arc discipline-associated, i.e., epidemiological. immunological.
or psycho or ncuropharmacological. The health-rclated disturbancec associated
with cigarctxc smoking are also age-associated manifestations that often require
prolonged periods of observation in intact animals; therefore. in vitro cellular
studies and even studic% with microbial nwdcls have been undertaken.
Man is the only animal that smokes (or his own satisfaction. Hence, stud-
ics are continuing on why man smokes and those diseases to which he is sub-
ject and which may be associated with smoking behavior. Such observations
supply inferences or associations but fail to demonstrate causes or mechanisms.
Animal models must be used for such experimentation.
Animal models for the study of the problems relating to tobacco smoking
and health arc not easy to devise. Smoke exposure is stressful for animals and
presumably prolonged periods of smoke exposure will be required. Extensive
studics have bccn undertaken during 1974 to determine the most satisfactory
animal modcl (or smoke inhalation studies. Mice have been chosen because
they have been inbred and selected for differences in response to stress, sus-
ceptibilities to different diseases, and differences in histocompatability and
antigcnic characteristics. Mice of different inbred strains differ in the capacities
of their liver microsomes to increase the levels of enzymes that metabolize a
carcinogenic hydrocarbon, 3-mcthykholanthrene, following the injection of
inducing agents. These enzymes, aryl hydrocarbon hydroxylases (AHHs), arc
inducible in mice of some strains so that cancer may be expressed while not
expressed in mice of other strains. These enzymes are under genetic control.
The availability of mice of inbred strains provides much genetic control for
the animal model. The interaction of environmental variables on essentially
identical genotypes also can be studied.
The human counterparts to mice of inbred strains are provided by identi-
cal twins. The Swedish Twin Registry, which has provided data on the smoking
histories and the incidence of pulmonary and vascular disease symptoms in
monozygotic and like-sexed twins born in Swedcn between 1886 artd 1925, has
been expanded to include similar data on twins born between 1925 and 1959.
This will provide additional data on a population that has a long life expect-
ancy and a very low lung cancer incidence. Another twin registry has been
started in Finland where the rcported incidence of lung canccr is about five
timcs greater than that in Sweden. This should augment srcady the numbers
of idcntical and non-identical likesexed twins that arc discordant (or smoking
experience and other cnvironmental exposures. Furthermore, the Iwins among
those receiving mulliphasic health checkups in the Northern California Kaiser
Permanentc Medical Care Program arc being surveyed as a potential source
of identical and like-scxed non-idcntical twins that have rathcr extensive medi-
cal and health histories and arc from different racial groups. Significant dilfer-
ences have already been reported in the pulmonary function tests of rcprc-
~
I@-~-
~
5

scntativc of the different racial gmups. Not only is informatiun being ohtainckl
on sm.rl.ing cspcricnce but on a wide range of cnvirunmcntal cxposwcs and
occupatrunal activiUCs in rclation to morbidity and mortality. 'I he twin rcgr.-
trics should providc a valuable source for many other .IUdic% thal will intludc
the cRccts of mulrip{c environmental variables on individuals of identical geno-
types and during thc process of aging.
Studies on familial predisposiuon to disease arc also being done. Thc
tenderscy for cancers to occur in some familics is grcatcr than in others. 'fhis
tcndency may be restricted to cancers of certain sites or to two or rnore sitc..
The predisposition of persons with known gcnctic constitutrons to acquire
emphysema also has been demonstratcd and may be caused by dcfrcrcncy of a
substance or substances that inhibit protcolytic cnzymes. lndividuals with this
genetic deficicncy, fonunately only a small percent of the population. arc par-
ticularly vulnerable in "smog" environments. Emphysema also occurs in inJi-
viluals without this specific genetic deficicncy' a special risk indicatur rs pto-
vided by the family history, an indication that other unidcntilicd genetic deter-
minants of predisposition may exist. The cpidcmiological projects of interest to
The Council involve mostly prospective studies of sclcctcd populations that pro-
vide special contrasts for genetic or environmental similaritics or diHcrenccs.
Basic research is also being funded on the chemical identrlicatron of
proteases and their inhibitors and how they interact. The levels of protca5e5 in
different organs and in normal, embryonic and cancerous u.sucs arc being
studied. Furthermore, cxtensive efforts arc being made to improve the nllti
assay, using human tissues, to promote its application to human cpidemiologi-
cal studies. Without basic investigation, the improvement and perfcction of
analytical techniques and the development of new or modified concepts of
discase prevention or control will be limited-
WILLIAM U. GARDNER, Ptt.D.
Scicntific Director
Canccr-Rclated Studies
AmcmE the di.ca..cs that have been a.sociatcd uatiaic:rlly with cigarette
.mo/,inb in I-lopul:,uon studics. carcinoma of the hmg has apparently received
thc grcatest attcntion. Ncvcrthclcss, this disca+c occur% only in a small minor-
ity even ol hcavy smokers. This cmphasizes that research on its pathogencsis
must include con.idcration of possible substantial differences among individuals
both in their genetic characteristics and in the numerous conditioning in0u-
cnccs to which thcy havc been subjected.
Many anomalous and contradictory aspects of the epidcmiological findings
havc been dcscribcd, and the great difliculty of conducting human .tudics with
controls adequate for resolution of these anomalies has been recognized. The
rca.un% for this arc both ethical and practical. Ilence, the crucial qucstions
"whcthcr, how, lu what cxtcnt, under what conditions, and in wlorn" smoking
could contribule to pathogcncsis of the disease remain unanswered.
An alternative approach to the problem of describing the interactions of
intrinsic and extrinsic influences in the process of carcinogcncsis lies in the
design of aiitahlc model systems involving animals, animal lissucs or cells or,
in .umc instances, human tissues or eclls. Superficial experiments with inade-
quatcly defrncd species or strains, whether whole animals or their tissues or
ccll.. will not -solvc thcsc problems. There is strong basis for doubting that
mou+c skin painting with stored condensates of the particulate phase of smoke,
altered in physical slate and in chemical composition and lacking most eom-
poncnts of the gas-vapor phase of "wholc, fresh normal smoke," can cstablish,
dcfinc or quantitatc the "carcinogenic hazard" of smoke inhalation by man
under lifc conditions.
Thc design of such model systems is a most exacting enterprise, since the
qucstion of the applicability of the results from thcse models to man in his
adual environmcnts niust be asked at every stage and evcntually answered.
lhc Council has, ncvcrtheless, undertaken to develop a series of model sys-
tcnts for the purposes mcntioncd and to explore strategies for relating the
results to man.
Carr'inogenesis as a 31u11i-Stage Process
Though the term "carcinogen" is often applied to individual chemical
compounds or nrixtures as if "carcinogcnicity" were a specific or unitary prop-
crty of matter, like a molccular weight, an absorption spectrum or a dipole
moment, it is wcll-known that Ihis is not the case. Induced carcinogenesis is
rather a procrss presumed to require a series of sequential changes in the bio-
logical systems of the host. Thcse, in turn- are presumed to depend both upon
the initial, genetically influenced characteristics of these aystems arsd also upon
a scrics of separate actions by the extcrnaiinciting agent or agents that require
quite specific physical or chemical properties and conditions. Such agcnts have
habitually been grouped together as "carcinogens" or "potential earcinogens."
Ncvcrlhclcss, it is well-known that a"carcinogen" for one spccies, strain or
tissuc under particular circumstances, may not be a"carcinogen" for another
spccies, strain or tissuc. or undcr other circumstances.
Metabolic modification may be necessary to convert the cxternal "poten-
~
Z.
6 7

lial carcinogcn" into a form that can directly attack sotuc particular anrcturc
in the ceil. Cclls may be more. or cvcn cxclusivcly. vulnerahlc lo such attack
during sumc particular stage of division. Hencc. influences that stimtdatc ccll
division or arrest thc process at a particular stagc may play a significant role
in thc proccss. Factors that alter the normal DNA repair mcchanism% may be
implicatcd in allowing abnormal eombinations to survive. ucreprc.sion of a
viral gcnonx or an orrcogene may be implicatcd. Whcn a normal ccll has bccn
transformed into a malignant one, the activitics of thc immrnc system in its
many manifestationc may determine whether the transformed ecll can survive,
clone and proliferate. Undoubtally Ihesc arc only a few illustrativic examples
of the kinds of factors involved and many others undoubtedly await discovery
and description.
A strategic goal in the research program is to identify those animal strains
in which such individual factors arc combined in a way to produce maximal
cancer susceptibility. Another goal is to create such combinations of traits by
genetic manipulation. As a corollary, the discovcry or production of strarns
with other combinations of such traits should help assess the relative roles of
such putative contributing facton to thc overall process of carcinogcncsis.
Systems for Chronic Smoke Exposure by the
Inhalation Route
For a long time the lung has been the organ of primary intcrest in The
Council's cancer research program. Thcrefore, its program has bcen premised
upon the concept that appropriate whole animal test systems should bc based
upon the chronic inhalation of fresh, whole cigarette smoke generated under
dc6ned conditions that simulate as nearly as possible those experienced by
human smoken, from cigarettes of defined and constant composition, and
administered in quantitated dosages to carefully selected and defined animal
species and strains.
Development of mechanical devices for accomplishing such exposures of
animals has bcen an exacting, time{oncuming task even after the estahlishmcnt
of criteria for acccptahle conditions. Despite the seventcen-year history of The
Council's smoke inhalation experience, recognition and definition of these cri-
teria have developed only with time. These have been detailed elsewhcre.
Two devices that meet many or most of the criteria reasonably well for
mice and other small animals have now been developed and a number of units
have been in trsc on a trial basis in Council projects. This experience has led
to rnodifxations arrd improvements on both.
With both types of device, current emphasis is being placed upon the
quantitation of dosage to the respiratory tract by use of separate tracer ingrcdi-
cnts for srnoke particulates and for gas-vapor phase.
Though humans smoke voluntarily, often probably for the relie/ of stress,
the conditions of smoke inhalation by experimental animals arc involuntary and
stressful so that the contributions of tcnsions to the overall experimental results
must be consirfcrcd carefully. Animal containers for usc in 'snwkc inhalation
devices have had to be designcd to minimize these cffccta. Mcthods for rnit.gat-
ing them, the role of habituation in reducing them and the use of uncaposed
"machine control" animals for estimating' their influence have all had to be
studied extensively to avoid complicating observations on smoke cffccts par u.
"I hout;h .mokr inhalation aurdics with animal% have been .ponsorcd almcxt
continuously by 'l he ('uuncil since its organization, the progressive improvc-
mcnts in controllcd and monitored systcros are expected to justify beginning a
new and more extensive series of experiments at a higher level of sophistication
within the coming year.
Lsscnually the same inhalation systems can obviou%ly he used in studies
hcaring on cancer, on cardiovascular diseases, on chronic pulmonary diseases,
on pharmacology and on other questions.
Selection of Animal Sub jects for Cancer Studies
Principles underlying the selection of animal species and strains for carci-
nogencsis studies have been described and these are being used as a guide to
selection of animals for the forthcoming new smoke inhalation experiments.
There appear to be more cogent reasons at this time for use of the mouse
than any other spccies, and this is our choice for present major purposes. Aside
from the obvious advantages of low cost, ease of handling, modest space re-
quircments, short life span, extensive existing information on their viral and
bacterial flora and methods of controlling these, there are others of even greater
importance.
Many inbred mouse strains exist which show greatly contrasting degrees
of susceptibility or resistance to carcinogenesis as observed empirically over
the years. These diffcrcnces arc now being related progressively to genetic
factors and interpreted to a significant degree in terms of biochemical mechan-
isms. In such mouse strains, moreover, the implications of competitive con-
cepts of the viral etiology of cancer have been explored much more extensively
than in any other species. Their immunological responses to carcinogenic
events have also been investigated quite intensively, though they are still in-
complctcly understood.
Despite the disadvantages of small lung size, meager volume of blood for
tests, differences from humans in lung structure, and the fact that mice are
nose hreathers, the use of mice from strains that have sharply contrasting
susceptibilities to the process of carcinogenesis presents a unique experimental
modcl. If a particular regimen produces carcinoma of the lung in one such
strain but not in another, and if these strains have been described with respect
to genetically influcnccd biochemical dificrences, the results may provide valu-
able inferences regarding the roles of such biochemical facton in the process
of carcinogenesis. Such inferences should furnish leads toward the search for
analogous biochemical bases for cancer susceptibility or resistance in man.
In a long series of preparatory studies, a number of biological and bio-
chemical characteristics deemed likely to be related to cancer susceptibility
have been studied in many inbred srrains of mice. A number of papers have
been published describing these studies and others arc in preparation.
Among these preliminary studies was an empirical survey to compare and
quantitac the relative (and contrasting) overall susceptibilities of a number of
mouse strains, both inhrcd and rarxlombred, to marginal, subcutaneous doses
ol several polycycGc hydrocarbons known from extensive experience to be
"carcinogenic° to rnice in the conventional sense. These hydrocarbons in-
cludcd 3-methylcholanthrcne (MCA) and bcnzo(a)pyrerx. The suhcuurseous
route was used because doses could be administered with precision, and the
8 9

treatmcnt zone kcpt undcr close scrutiny. On the basis of a carcfully dcvr.cd
scoring system, very striking differcnccs in tumor responscs were found anwng
these strains.
Strains sclcctcd from the spectrum of varying subcutancous .usccptihihtics
wcre then subjected to dircct instillation of the same polynuclcar hydrucarhons
into thc lungs, in various media and by scvcral tcchniqucs. Squamous ccll Iung
carcinomas have arisen at ditTerent rates among these animals, showing that
sume strains at least arc susceptible to this disease. Continuing experiments arc
expcctcd to reveal more fully the magnitude of these strain JilTcrcnccs. With-
out the assurance that the animals to be used in smokc inhalation expcrimcnts
can devclop the discase under investigation, the intcrpretation of negative rc-
sults from such experiments would be impossible.
The Metabolic Activation of Polycyclic
Aromalic IlyrlrocarLons (PdIL)
Some PAHs, at least, must be metabolized to active forms before Ihcy
can transform cells, induce tumors or produce mutations. This acuvalion is
accomplished by enzymes of the family termeil "mixed function oxidases"
found in the microsonxs of the cells of many tissues. The cnzynxs Ihat pro-
duce the change arc designated as aryl hydrocarbon hydroxylaxs (A(ills).
These enzymes occur in cells of many tissues of both man and animals at
moderate levels and arc probably in some way necessary to life. In some ani-
mals, however, exposure to certain polycyclic aromatic hydrocarbons stimulates
production of an increased level of the enzymes, while in others it does not.
Those that respond to such exposure by production of more (and perhaps
different types of ) AHH arc said to be "AHH induciblc."
fn the expcriments citcd. AHH inducibility ranged widely in mice of
different strains and was correlated with the susceptibility of the strain to MCA-
induced subeutancous carcinogenesis. This may well be one clue to the bio-
chemical difference between more susceptibk and less susceptible animals with
respect to induced cancer as contrasted with spontaneous cancer.
Many other substances can stimulate AIIH production in "inducible"
animals. 7bese include internal agents such as corticosteroid hormones and
bilirubin external ones including barbiturates; chlorinated hydrocarbons such
as DDT~and certain defoliating agents; and compounds that occur in several
vegetables. Exposure to sueh compounds in thc environment may, thcrcfore,
inercsse some aspects of cancer susceptibility in both animals and men who
arc AHH inducible.
Inducibility of the AHH system by MCA has been reported to be gencti-
cally based in mice. Susceptibility to induction by mcthylcholanthrcnc was
reported to segregate as a single autosomal dominant gene in crosses between
inducible and rwn-inducibk strains.
Published reports of these mouse studies from The Council program stim-
ulated other investigaton (not Council sponsored) to study AHH levels and
inducibility in man, to teat the concept that this function might be under
geactic control iu man as well as in mice.
Fo[ several tYasorta ta+ch determinations in man have becn much more
dif8ettlt than in mioe. 1Le Council tutdertook to assist the research of the
invcstil;ator% aliuJ.d to. Al.o. looking to Ihc practicalitics of cxrcnding such
titudic% to large hunian gruups fur elucidation of the modc of inhcritancc, l hc
C'puncil inaugur:itcJ aJJiliunal cfiorts to improve the AHIi asay systcros with
respcct tu scn.iUvity, accuncy, rcpGcahility and speed. Populations of lung
c:rnccr patient% as wcll as human family aggrcgrations (kindreds) charactcr-
i.rcd respectively by unusually high and very low familial levels of cancer inci-
dcncc. alrcady under study for other purposes, arc available for survey as
mcthodolugical dcvclopmcnts permit.
Other studics rclating to AHH induction include more dctaileJ investiga-
lion ol thc metabolic routcs (or bcnzo(a)pyrene, of the intermediates formcd.
the activilics of the.c in cell systems, the enzymes that produce and destroy
thcm, and of agents that may block their formation.
Inur.urtororrrpr7tence of Alorrse Strains
Mice of all the contrasting strains that arc eandidates fur uw in chronic
cigateue smoke inhalatiuu studies are being given an cxtcmive battery of pre-
linrinary tests to dctcct any large differcnces in the ba%ic competence of their
imrnunc systems. "l hc tcsts are then repeated during experimental regimens to
detect any consistent changcs in the hope of determining whcthcr immunologi-
cal impairment may be a factor contributing to the end results of long term
cxperiments.
A/utagenPSis arrd RPpair blerhaniarns
Metabolic activation of potential carcinogens and alterations in immuno-
compctcncc arc two of Ihc scqucntial changes that may be involved in the
multi-stage process of carcinogenesis in many cases. It appears that both in-
cludc genetic bascs for susceptibility as well as for the intervention of external
agents in an interplay.
There is a widespread belief that the conversion of a normal cell into a
potentially ntalignant one is closely related to the process of mutation. Sensi-
tive model systems for appraisal of "mutagenic potential" of environmental
agents suspected of a role in carcinogencsis' have been devcbpcd by several
investigators. In The Council program, some of these arc being assessed for
their applicability to tobacco smoke and its major fractions as an adjunct to
the inhalation experiments.
When ccllular components, especially those in the nucleus that are be-
licved to rcgulatc the activities of the cell, including division, have been
changcJ, perhaps by mutagenesis, into a potentially malignant stute, ir is widely
believed that nornul repair mechanisms may reverse these changes by climinat-
ing the modificd ccll componcnts. A deBciency or depression of such repair
pwcntial may constuute another step in the overall process of careinogertesis.
Model .ystcnrs proposcd for assessing the efficieney of repair mechanisms are
under study in the progrant as another step in the investigation of contrasting
auscephbilitics in mouse strains.
10
11

tiruuk. 1rrlrulrNiorr in Re/afiun to the
I:nrcinr.Rerreaia Proi'eaa
The principlcs, conccpts and developmental studies that have been dc-
scritxd hriclly arc bcing incorporated into the design o( the new scrics of long-
term chronic cigarette smoke inhalation experimcm.. In these cxpcrimcnts.
micc will be used that havc the combination of factors must conducivc to
cancer srrsccptibiliry. on the basis of prescnt knowledge. For the rca+uns our-
lincd, mice of other suains with contrasting su.ccptihiliucs, on the basis of
available biochemical information, will be employed for comparison. I: un-
cquivocal squarnous-ccll carcinomas of the lung should develop at a suhst:rnlial
kvcl in some strains and not in others, useful leads into the study of human
susccptibility ntight be suggested.
By "unequivocal" lung carcinoma is meant a cancer analoFou% to the
human disease not only in morphology but in bchavior, being aggres.ivcly in-
vasive, metastatic and rapidly fatal. Diagnoses arc to be made independently by
several experienced pathologists. At the present stage, "prc-canccrous" lesions.
though they are to be described and recorded, arc not regarded as acceptable
end-points. In one Council-sponsorcd project of several years' duration, a
Sendai virus infection invaded a colony of mice that were tinder chronic smoke
inhalation exposure. Lung lesions were found that could easily have been mis-
diagnosed morphologically as early lung carcinoma. but which were ultimatcly
shown to be attributable to the virus, to regress in many cases and to occur
in controls not exposed to smoke. This experience recommcnds grcat vigilancc
with respect to prevention and dclection of infections in srnokc-inhalation stud-
ics, as well as caution in diagnosis.
Obviously, results from such mouse experiments could not be extrapolated
direcrly to humans, since the highly susceptihle mice repre+cnt conthinatwns of
characteristics that may occur never or rarely in man. Development of the dis-
ease in all strains would provide less guidance of the kind mentioned. Its oc-
eurrence in none of the strains would suggest that the treatment is incapable of
bringing about the necessary sequential changes of the carcinogenic process.
In any case, however, the model system should have other important u.ccs.
Humans do not live under the rigidly controlled "hot-housc" cnvironmcnts pro-
vided for experimental mice. They are generally cxpo.ed to considerable
amounts of "potential carcinogenic agents" in the contemporary environment.
The model can be uud to explore conditioning effects ol small chronic doses
of these agents. The human situation can be simulated to some degree in mice
by administering "priming" doses of such "careinogens," too small to produce
cancer alone, and rhen subjecting these mice to chronic smoke inhalation to
determine whether the latter shows somc type of "promotcr" activity. Sintilarly,
the possible synergistic roles of controlled bacterial and viral infcctions, ex-
po%ure to agents that produce inflammation, mechanical damage, ircat trauma.
presence of lung in(arcts, hormone and vitamin ddieicncics or exces.es. deposi-
tions of asbestos, immunosuppression or stimulation. liver dysfunction, and
many other factors common to human experience can be studicd cmpirrcally or
on a rational basis.
Ruecrcr C. Ilocrcr.rr, Pit.D.
Rcscarch Director
Abstracts of Reports
f:oll4,wing are ahstracts, approved by the authurc, of reporta on new re-
scarch acknowlc.lbing support front Thc Council that have appeared in .cicn-
riGc journals since publication of the 1973 Report. 'I he name of the recipient
iti in italics.
'Ihc ah.tracts arc grouped tinder thc%c headings: 1.. Canccr-Rclatcd Srudics,®
11. 'l hc Respiratory Systcm, 111. (Icart and Circulation. IV. Ncuropharmacology,
anrl I'sYchnPhYaolobY V. Pharmacology, V1. Immunology and Adaptive Mech-Ix
i
V
an
srns,
11. Epidcmiology, VIII. Miscellancous.
1. Cancer-Related Studiea
TRACHEOIIRONCHIAL EPITHELIAL MULTINUCLF.AT(ON
IN MAI.IGNANT DISEASE
During a continuing study (2,9R3 cases thus far) of trachcohronchial ex-
foliated cytology in surgical patients subjected to endotracheal anetithesia. the
authors notcd that individuals with known malignancies sccmcd to have un-
usually numerous multinuclcated ciliated cells. Further examination of smears
taken front 112 patients known to be suffering (rorri, a widc variety of malig-
nant tumors confirmed this observation. Muhinuckation was 2.08 times more
frequent in this population than in a supposedly malignancy-free control group
matchcd by scx, age in dccadcs, and smoking habit. It is hoped that rccog-
nition of this phcnomcnon may Icad to the development of a new test for
the diagnosis of occult canccr, and may open new pathwayc (or investigation
of canccr-host rclationships. The authors are currently tackling the first oh-
jcctivc by looking for occult cancer in controls who have high percentages of
trachcobronchial epithclial multinucleation.
Clralon, J. ci a!.
Science IS3:525-52G, 1974.
O1her.rrpporr: National Cancer Institute.
From the Department of Ancsthesiology, Albert Einstein College of Medicine of
Yeshiva University. f3ronx, N. Y.
THE CF(.LUI-AR I~.VF.NTS ASSOCIATED WITH REGRESSION AND
PROGRESSION OF MURINE (MOLONEY) SARCOMAS
Previous histopatholovic classifications of Moloncy sarcomas have diltercd
wirlcly, ranging from a bcnign, reparative inflammatory reaction to mescn-
chymal sarcoma. Furthermore, a complete sequential analysis of the cellular
inflammatory cvcnls accompanying both tunwr proFrosion and rellre.sion is
still Ircking. lhe authors, thcrefure, ehinc to induce Moloncy sareorna in neo-
natal and Adull mice jn ordcr to characterize both its histologic nature and
v
` 12
13

the coursc of events that dcvclops following the injcction of its tran.plantahlc
cells. In ncomatcs. intramuscular injections of either 10' or II)° cclls Iruor a
cultured murinc (Muloncy) sarcoma line inkluccd ncoplasms Ihal pn+)uc..cJ,
In adults. only the larger dose pfoduccd this clicct; adult micc receiving 10'
cells usually dcvclopcd tumors that regressed. The growths wcrc cxaminc.l hy
light microscopy at 2-3 day inmcrvals throughout the course uf their dcvclup-
ment and subscqucnt regression or progression. Initially, all tumors wcre in-
filtralcd with polymorphonuclcar Icukocytcs - mainly ncutrophils - and cdcm:r
was extensivc. fly thc end of the second weck aftcr inoculation, this acute in-
flammatory infiltrate had been replaced in adult mice by one consi.ting of
mononuclcar cells; neonatal mice never devcloped significant numbers of these
inflammatory cclls in their tumors. Of particular significancc, sincc munonucicar
inflammatory cells were associated intimatcly with tumors during the proccss
of rcgression, was thc disappearance of these cclls 12-14 days aftcr inocula-
tion frorn tumors datined to progress in adult micc. Hyperplastic changcs
wcrc found in the corticcs and medullae of regional lymph nodcs draining
both progressing and regressing sarcomas. Thc devclopment of secondary
neoplasms was common, and the distribution of these lesions was rclatcd to the
ages of mice at the time of inoculation.
Russell, S. W. and Cochrane, C. G.
lnternationalJournalof Cancer 13(1):54-63, 1974.
Other support: U. S. Public Health Service.
From the Department of Experimental Pathology, Scripps Clinic and Kcsearch
Foundatioo, La Jolla, Cal.
HEREDITARY LYMPHOSARCOMA IN WH RABBITS AND
HEREDITARY HEMOLYTIC ANEMIA ASSOCIATED W1Tli
THYMOMA IN S1 RAIN X RABBITS
Among their "partially inbred" rabbit strains, the authors searched for
those genes which produce susceptibility and resistance to certain types of
tumors. They found such a situation in the wirchair (WH) strain: lymphosar-
coma occurs at a mean age of eight months; susceptibility is conferred by a
singk autosomal recessive gerx designated Is. There is tcntativc cvidencc which
points to the presence of a C-type RNA gcnomc coding for the interspccics dc-
terminant of the group-speciflc antigen. Highly positive reactions were obtained
with potent antisera produced in rau to the p-AGs of murinc C-type virus.
Complete (infectious) C-type particles have not bcen found by electron micro-
scopy; thus, ccll-free transmission has been negative so far, and assays for
"hdpcr" activity have been inconclusive. However, cellular transmission is
successful upon inoculation of lymphosarcoma tissue into (ctuses. Presumahly,
the !i gene confers susceptrbiGty to virus-induced tumorigcncsis. The invcsti-
gaton have also observed thymomas associated with hereditary hcmulytic
anemia in strain X rabbits. In these rabbits, which are genetically related to
strain WH, anemia occurs at about five months; susceptibility is contcrred by
a siogk autosomal recessive gene, symbolized ha. Thc data for these two dis-
eaaes are compatible with both conoepts of genetic susceptibility and the
vcrtical tnnsmisaion or inheritance of a viral jenome.
in
Alrirr, 11. and Fox. K. R. !}~
Jtilrliurbrca l/urrnarr+lugir'u (No. 39: Unifying Conccpt. of I.cukcmia):72-93, ~
1973.
Otlrrr auplturr: National Institulcs of Health and the National Cancer In-
slitutc.
From Thc Jackson Laboratory- Bar Harbor, Mc.
INFI.UE?NCE OF PRi:INFfiCT1ON OF C57BL/6 MICE WITH (;RAFFI
l.1{UKF.MIA VIRUS ON 3-METIiYLC}iOLANTHRIiNE-INDUCF.D
SUBCUTANEOUS SARCOMA
W
Do oncogenic agents which induce different types of ncoplasms have an
effect upon each other? This study on the combined cfkctc of the Grafli
Icukcmia vinu and 3-mcthylcholanthrcnc (MCA) ancmptc to answcr this
qucsuon. It investigates the mutual influences of virus-induced leukemia and
chernically-induced sarcoma in C57B1./6 mice and examinec furthcr the latency
pcritxl as a dctcrmining factor in the co-oecurrence of induced neoplasms
dilTcring in ccll type. Rcsultc from these cxpcriments showed that when
C57A1./6 mice were given )oth Graffi Ieukcmia virus and M(-A the devclop-
mcnt of either Icukcmia and/or sarcoma was dependent on the dene of each
carcinogen given. A high dosc of virus reduced sarcoma inductiim hccause.
due tu the high incidence of Icukcmia. the survival timc of thc mice was Icss
than the averagc latency period requircd for tumor development. A high dose
of MCA (3(X)rg) increased the incidence of lcukemia induclion by a low dose
of virus without affecting the incidcncc of sarcoma. 7his occurred since the
latency pcrio.l for sarcoma and Icukensia coincided and 'SS'o of the mice
developed both leukemia and sarcoma. The combination of a low drxe of virus
and a low dose of MCA did not alter the incidence of Ieukcmia or sarcoma;
however, with this combination of virue and chemical c.rrcinogcns. the average
latency period (or thc development of leukemia was delayed and the average
latency period for sarcoma induction was acceleraled. Crafli virus failed to
increase the incidence of MCA-induccd sarcoma under the conditions studied.
Whitmire, C. F. and Salerno, R. A. (Microbiological Arsociates)
ProcrrdinRs of the Society /or Esperimtntal Biology and Mrdicint 144(2):674-
678, 1973.
Other sapport: National Institutes of Health.
From the Department of Viral-Chcmical Oncology, Microbiological Ascociates,
Bethesda, Md.
HYDROCARIION-MF.TABOLI7.ING ACTIVITY OF VARIOUS
MAMMALIAN CE(.LS IN CULTURE
Recent in viro studies strongly suggest a relationship betwcen levels of
hydrocarbon-metabolizing enzyme activity and sensitivity to polycyclic aro-
matic hydrocarbon-induced chemical careinogerxsis. In the limited number of
in virro systems available. the levels of these enzymes may strongly in(luence
the sensitivity of cclls to transformation induced by certain polycyclic aro-
14 15

matic hydrocarbons. Thus. before starting any large scale in rirrn Iransforma-
tion program, potential human cell lines should hc scrccncd so a, to idcntify
thosc with high enzyme Icvcls. This approach has hccn panicularly uscful in
cluciJating the relationships between hydrocarhon-mctaholi/ing cnxyrnc activity
and sensitivity to hydrncarbon-induced cytotoxicity. Hcrc. the awhors comparc
two procedures (or measuring the enzymcs. The one designed tn mcasurc
bcnzolrlanthraccnc-irxluced aryl hydrocarbon hydroxyla.c activity couW dctcct
and quantify enzynx activities in low passagc rodent cclls, hut could not
rcproJucibly dctcct IcvcJs in intermediate or high passage muu.c, rat, or human
cells. The method designed to rneasure the ability of a cell to convert hcnr.o(a)-
pyrcne from an organic-soluhlc to an aqueous acctonc-soluhle form. proved
more reproducible. When nsodified, this particular technique proved to be an
effective screening test for the detection of those lines with highcr lcvcls of
hydrocarbon-me(abolizing enzynxs.
Kouri, R. E., Kiefer, R. and Zimmerman. E. M. (Microbiological d csocinres)
In Vitro 10(1 & 2) :18 ?5, 1974.
Other sr.pport: National Institutes of Health.
From the Department of Vinl-Chcmical Oncology, Microbiological Associates,
Bcthcsda, Md.
GENETIC CONTROL OF SUSCEPTIBILITY TO 3-METIIYI.-
CIIOLANTIfRENE-INDUCED SUBCUTANEOUS SARCOMAS
The authors report on their use of a mouse gcnctic systcm to cxtcnd
their observations on the relationship between aryl hydrocarbon hydroxylase
(AHH) inducibility and sensitivity to 3-mcthylcholanthrcnc (MCA)-induced
lumorigencsis. Observations reveal that AHH-inducible mice are approximately
12 times more sensitive to MCA-induced tumorigenesis than thcir noninduciblc
littermates. The type of parental cross (maternal influence) plays no role in
this sensitivity. Host-regulated expression of the group-spccihc (gs) antigen of
type-C RNA viruses, although also segregating in this genetic system. does not
seem to play a major role in this enhanced susceptibility to MCA carcino-
genesis. Results are discussed with the view that the enhanced scnsitivity of
the AHH-inducihle animals probably results from rapid and efficient mctab-
olism of the chemical to its ultimate carcinogenic form. Recent information
suggests that these observations may be analogous to what occurs in human
populations wherein the degree of AHH inducibility is genetically controlled
(probably by a single locus), and inheritance seems to be codominant. Thus,
thers may be a correlation between the presence of (or susceptibility to) lung
carcinomas and the alleks regulating expression of high or intermediate in-
ducibility. lf so. the genetic system presented here may provide a valuable
model for studying Ibis problcm in human populations.
Kouri, R. E., Ratric, H., III, and Whitmire, C. E. (Micral,ioloy;icaL.tssociatcs)
Inrernarlond Journal o/ Cancer 13 (5 ):714-720, 1974.
Other support: National Institutes of Health.
Fnom the Dcpartnxnt of Viral-Chemical Oncology, Microbiological Associates,
Bethesda, Md.
IiN('AI'Slil.A l ION OF LYMI't1(X:Y'1 [i DNA BY VI:SICUI.AR
SfUMAl7fIS VIRUS
Scvcr.kl : nimal viru.cs arc known to incorporatc hoat DNA during their
rcplication : nd ncuuration, but this proccss was generally thought to be char-
actcristic uf oncogcnic DNA viruses with a nuclear phasc of replication. Hcrc,
howcvcr, the awhur. demonstrate that an RNA virus which is rwt considcred
oncogcnic- has no known nuclear phax in its rcplication, has its own RNA-
dcpcndcnt RNA polymcrasc, and shuts ofl host DNA synthesis can contain up
to 30"/0 of its t;cnctic rnais as DNA. In addition to viral RNA, vesicular
stnmatitis virus (VSV), grown on thc WILs-3A line of continuously growing
human lymphocytcs, contains DNA which is found in both the B and T virus
particles and is resistant to Jcoxyribonuclcasc. This DNA is intimately assa
ciatcJ with the virus and appears to be incorporated into the viral ribonucleo-
protcin structure produced by treating VSV with Nonidct P40 followed by
('sCl isopycnic banding. In conlrast. virus grown on BHK 21-4713 fibroblasts
has no Jctcctahlc DNA. The virus-associated DNA has an isopycnic density
of 1.699 g X cm 3 in CsCl, identical to that of human DNA. 11s average
molecular weight is 9.0 x 10", as determined by velocity sedimentation in
sucrose density gradicnts, and studies of its contour length in the electron
microscopc. The DNA'DNA rcas.ociation kinctics of this particular nucleic
acid demonstratc that it is of host origin and rule out the possibility that it
originatcs from coNaminating microorganisms or mitoclwndria. lhe analytical
coniplexity of the virus-as.ociateJ DNA shows that 50% of its sequences are
humologous to thc rcpcatcd DNA scqucnccs of human DNA and that thc
rcmaining 50% arc homologous to human unique sequcnces. On the average,
there is one molecule of DNA for each four virion particles. Whether or not
viruscs such as VSV arc capable of oncogenic information "transduction" is
unknown, but it is a possibility which can he tested.
Kingsbury, D. T. and Lcrnrr. R. A.
Prrxrcdint,s n/ rhr Nutional .IroJnny of Scitncr.s of the United Statrs ol
i(mrrica, 71(5):1753-1757, 1974.
Othrr support: National Cancer institWe, National Foundation - March of
Dimcs, and U. S. Public }lealth Service.
Front the Department of Medical Microhiology, Univcrsity of California Col-
Icgc of Medicine. Irvine. and the Department of Experimental Pathology,
Scripps Clinic and Research Foundation, La ]olla. Cal.
DIFFERENTIAI. RL'SPONSF. OF SNF.LL:S AND C57 BLACK MI('F.
10 ('HRONI(' INffA1.ATlON OF CiGARETTE SMOKIi. PULMONARY
CAR('IN(XJIiNF.SIS AND VASCULAR ALTERATIONS IN
LUNG AND HEART
Do genetic diffcrcnccs hetNccn mouse atrains influcncc their re.ponse to
chronic inhaletion of cigarette smoke? The question is expiorcd in this study
16 17
